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ABSTRACT 
Th~ work described in this thesis deals with the effects of ionizing and non 
ionizing radiation, upon rodent tumour metabolism and growth and comparable 
properties of 816 melanoma cell cultures. Metabolic processes investigated were 
related to energy production and possible repair mechanisms after radiation 
\ 
induced damage. Further, some effects of the drug mitoxantrone on energy yield 
were also studied 11 in vivo 11 and 11 in vitro". 
Three strains of mouse (CBA, BALB c and WHT) were used and one strain of rat 
' {WAG/Rij). Their tumours investigated in vivo were CaNT, rhabdomyosarcoma, 
Fib/t and Rl respectively. The following sources of radiation were used: 100, 
. 60 250 kVp of x-rays, Co gamma$, 8 MV x-rays (from a linear accelerator), and 
') . 
magnetic fields of 0.5 Tesla (constant) and 5 x 10- .... Tesla/m (varying). The 
biochemical parameters measured were levels of adenosine-5'-triphosphate (ATP) 
isocitrate dehydrogenase (ICDH), glucose-6-phosphate dehydrogenase, (G6P-DH), 
phosphomannose isomerase (PMI) and tissue sulphydryl. This was done with 
tumours under normoxic and hypoxic conditions. Growth rate and nuclear magnetic 
resonance relaxation time constants T1 and T2 were measured in CaNT tumours. 
Their ultrastructural changes using electron micrographs were investigated after 
x-irradiation. Further, the effects of mitoxantrone upon ATP production were 
measured in CaNT tumours. In addition the r-adiation response of 816 l!lelanoma 
cells after exposure to 60co gammas was studied, with and without treatment 
using mitoxantrone. 
Changes in levels of ATP and activities of G6P-DH and ICDH were observed at 
different times after irradiation in the varying conditions studied, but no 
significant change in tissue sulphydryl levels was detected. Further it was 
shown in 816 cells that radiosensitivity could be modified using mitoxantrone , 
(which reduces ATP production) such that a greater cell kill could be achieved. 
Tumour growth ratE slowed with exposure to the magnetic fields. 
ii 
The results which can be considered to be interesting from a basic science point 
of view, may also be indicative of a complex metabolic response to irradiation. 
This work has described relations between different qualities of radiation and 
aspects of energy producing metabolic reactions in the tumours investig~ted. 
iii 
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CHAPTER 1 
INTRODUCTION 
Cancer has caused much pain and suffering through the ages, and a great deal of 
effort has been and is presently being expended to research more effective means 
of treatment of this scourge (1). The importance of this continued effort can 
be gauged from the estimate of several scientists that the spectrum of this kind 
of disease now affects over 30% of the Westernized world {2, 3). One of the 
treatment modalit~es now used is irradiation with ionizing radiation, and it is 
estimated that about one fifth of cancer sufferers receive radiotherapy at some 
stage of their disease (4). 
Radiotherapy has its origins in the realization very soon after the discovery of 
x-rays by. Wilhelm Roentgen that ionizing radiation could damage cells. 
Radiation oncology has made great strides especially in the last 45 years, and 
radiation is very much established as one of the three major methods of cancer 
treatment, the others being surgery and chemotherapy (5). 
Recent evidence suggests that cellular oncogenes are associated with cellular 
malignant transformation, presumably through effects on normal differentation 
genes. Perhaps regulatory genes turn off oncogenes, at the appropriate time in 
development. Such regulatory loci could be the anti-oncogenes. A deleti<>n or 
mutation stopping the normal function of an anti-oncogene would allow 
inap~ropriate transcription of the corresponding oncogene. This sequence of 
events could cause a tumour if if took place in a cell type that is responsive 
to that oncogene. Malignant transformation may also be related to 
proto-oncogenes which are precursors of oncogenes (6) and can be conserved 
during evolution. Relatives of human.proto-oncogenes have been found in DNA of 
a number of mammals, birds and even in the fruit fly. The proto-oncogenes would 
presumably not have been conserved, almost without change, 
they had some important normal cellular metabolic function. 
in the genome unless 
It is not exactly 
known what the role is of such genes in normal metabolism, but there are some 
indications that it is associated with control of cellular proliferation. With 
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the present state of knowledge concerning oncogenes and proto-oncogenes it seems 
that in normal cells there are genes present, which can suffer either mut~tion 
or misregulation. These changes can transform a normal cell's phenotype to a 
premalignant or malignant phenotype (7, 8) with possible loss of control of cell 
division, invasiveness and metastasis (9). It is important to realise that 
cancer cells contain all the biochemical mechanisms responsible for implementing 
all cell functions, many of which operate as in normal cells. 
Nevertheless, an important difference between normal and malignant tissue lies 
in intercellular organisation. There appears to be decreased cohesion between 
c~ncer cells. The tumour cell membrane has many defective junctions {membrane 
' 
passageways) and often modified numbers of beta-adrenergic and other hormone 
receptors in the membrane (10, 11). Owing to the haphazard manner in which the 
vascular pattern develops in malignant tumours, abnormal cellular spatial 
relationships exist within the tumour. This results in the malignant tumour 
having in addition to oxygenated cells, which may be dividing or non-dividing, 
poorly oxygenated cells (hypoxic cells) which would be located some distance 
from the blood vessel. There will also be areas within tumours, which have been 
starved of all nutrients including oxygen, where the cells are necrotic (12). 
As a result of irradiation of tumours with ionizing radiation, three gross 
effects are to be expected. Firstly, some cells will suffer reproductive death, 
that is, they are effectively sterilized. Secondly, some cells will suffer some 
damage which fs potentially repairable, and thirdly, there may be no observable 
effect. There is ongoing debate as to what part of the cell must be "hit'' so as 
to cause reproduction death (13). It has been suggested that the critical 
intracellular target may be deoxyribonucleic acid (DNA) for most cell types 
(lymphoid cells are an exception), although the possibility exists that damage 
to a membrane protein complex located near DNA, or to the nuclear membrane 
itself, cannot be excluded (14, 15, 16). It may be that radiation causes 
' 
widespread lesions at a number of intracellular sites, with resultant cell death 
or with resultant damage in the cells which is potentially repairable {17, 18). 
It ca~ be deduced that the type and magnitude of radiation damage and its effect 
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on tumour cell metabolism will depend to a large degree on whether or not the 
potentially repairable damage is indeed repaired (19, 20, 21). If the damaged 
cells had no repair capability, the cells might tend to amplify the damage, 
which would in turn lead to metabolic disturbances and finally cell death, i e 
an increased cell kill might be expected. Consequently if the potentially 
repairable damage is repaired, a decreased cell kill would be expected (22, 23). 
One of· the objectives of this thesis was to enquire into some of the biochemical 
factors in terms that might change following ionizing radiation, with particular 
emphasis on those which may be related to cellular repair processes (24, 25, 
26). However the full implications of biochemical perturbations induced by 
I ' 
radiation are not yet fully understood. The present work attempts to improve 
understanding of their significance. 
The biochemical parameters selected for investigation were adenosine 
triphosphate, isocitrate dehydrogenase, glucose-6-phosphate dehydrogenase, 
phosphomannose isomerase and thiols. Tumour cell ultrastructure was 
investigated by electron microscopy following ionizing frradiation. 
The second major aim of this thesis is to examine some effects of magnetic 
fields in experimental tumours. The tumours are basically diamagnetic and 
magnetic fields can deform atomic and molecular structures and exert forces and 
torques on particles in the tumour cell (28, 29, 30). Molecular or subcellular 
structures with anisotropy in magnetic susceptibility can be influenced by a 
twisting force, depending on the orientation of the structure to the applied 
magnetic field (31, 32, 33). The field also can induce certain spatial and 
directional asymmetries in electron currents (11, 34). These physical effects 
in turn modify vat~ious chemical processes as well as some electrochemical 
J 
processes which may result in a variety of biological effects. The parameters 
selected for study in magnetic fields were tumour growth rate and the specific 
activities of: 
(a) Glucose-6-phosphate dehydrogenase (G6P-OH) 
(b) Phosphomannose isomerase (PMI) 
- 4 -
The opportunity also arose whereby it was possible to determine T1 (spin-lattice 
relaxation time) and r2 (spin-spin relaxation time) in murine tumours using a 
magnetic resonance imager (35, 36). 
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CHAPTER 2 
RADIATION BIOLOGY AND METABOLIC RESPONSE TO INJURY IN EXPERIMENTAL 
RODENT TUMOURS 
2.1 Historical considerations: 
(a) Ionizing radiation. 
It is interesting to consider some of the historical aspects of the 
development of basic research in radiation biology (37). Some new 
lines of research were initiated by some quite accidental observations 
once the scene had been set by the discovery of ionizing radiation. 
Becquerel, who absent-mindedly carried a radium preparation around in 
his coat pocket, found this· caused an inflammation of the skin and 
subsequently cancer due to this radioisotope was described. Soon 
after Wilhelm Roentgen's discovery of x-rays in November 1895 
considerable information was obtained about the physical properties, 
interactions with matter and biological effects of x-radiations (38). 
After the discovery of x-rays, there were many scientists who, 
marvelling at their penetrating power, never tired of looking at 
images of the skeleton of their own hands. However, their enjoyment 
was soon dampened by the observation of peculiar changes in the 
exposed skin. The beginning of the development of this 
multi-disciplinary area of research was characterized by qualitative 
radiation biology which followed these initial observations and was 
related to morphological and descriptive investigations. Later on, in 
the late 1940s the advance of further basic knowledge in chemistry, 
physics and biology led to the development of radiation biology as a 
quantitative science (39). This period is characterized by the use of 
mathematical and statistical methods. A high point of interest was 
realised when the books of D.E. Lea (1946), N.W. Timofeeff-Ressovsky, 
and K.G. Zimmer (1947) finally established radiation biology as an 
independent branch of science. 
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During the past four decades more insight developed into biological 
phenomena induced by radiation. This understanding was related to 
study of modifying external conditions, for example altering 
temperature, tension of o2, or adding substances that changed 
radiation sensitivity (40). Also results using radiations of 
different qualities were obtained and a number of explanations 
attempting to interpret the phenomena of radiation damage and repair 
mechanisms in cells were made. (41, 42, 43, 44). 
(b) Magnetic Fields. 
There is experimental evidence concerning the possible influence of 
magnetic forces on living organisms (45, 46). Several investigations 
have reported a delay in growth as an effect of magnetic fields both 
at the cellular level 11 in viV0 11 and 11 in vitro" as, for example in 
tumour tissue as well as in whole organisms such as mice (28, 47, 48). 
Some representative historical data of biomagnetic effects on growth 
(11) are given as Tables (2.1) and (2.2). 
The existing experimental results of the effects of magnetic fields on 
metabolic rates are difficult to interpret. Some reactions are 
accelerated, some are decelerated and some are not affected at all by 
magnetic fields. Mechanisms whereby magnetic fields might influence 
metabolic changes include macromolecule orientation change~ leading to 
modification of both biochemical kinetics and membrane permeability 
(49, 50, 51, 52). Also the magnetic dependence of the triplet yield 
in the formation of paramagnetic metabolic transients in the cells is 
affected by magnetic fields (53, 54). 
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TABLE 2.1: BIOMAGNETIC EFFECTS ON GROWTH RATES IN LIVING ORGANISMS 
Organism Fields (T) Exposure Effects Observed 
Young mice 0.59 30-60 days Retarded weight gain 
Guinea pigs 0.7 500 hours Necrosis, edemas, 
hemorrhage 
Rabbits, cats, rats 0.2-0.3 Dystrophy in neuroglia 
Frog embryo 1 Development retarded 
Frog embryo 0.7 Development retarded 
Pigeon embryo 4.7 Development retarded 
Chicken embryo 0.003 2 days Anomalous growth 
Pigeon embryo 0.0005 Development retarded 
Drosophila 1.2 1 hour 100% mortality 
(fruit fl i es) 
Bacteria, yeast 1.1 No effects 
Bacteria, yeasts, 0.3 48 hours No effects 
molds 
Plants 0.02-0.21 Growth inhibition 
Plant 0.7 Faster growth 
Algae, paramecium 0.1 7-21 days Reproduction rate 
decreased 
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TABLE 2.2: BIOMAGNETIC EFFECTS ON GROWTH RATES IN TUMOURS 
Tumours 
Epidermoid carcinoma 
KB 
He La 
He La 
Hela, KB, W138 
Ehrlich adenocarcinoma 
Ehrlich 
Ehrlich 
Ehrlich, S-37 ascites 
Ehrlich, S-37 ascites 
Mice tumors (H2712, C3HBA, 
T2146) 
Crown gall tumor 
Heteroploid L-29 mammalian 
cells 
Diploid WI-38 mammalian cells 
Adenocarcinoma 
Fields {T) 
0.4 
0.5-0.77 
0.12 
0-0.12 
0.15-0.17 
0.3-0.4 
0.73 
0.73 
0.44-0.8 
0.3-0.45 
0.01-0.22 
0.5 
0.5 
3.8 
Exposure 
3 days 
1-3 hours 
Few hours 
18 hours 
3 months 
7 .days 
7 days 
18 days 
Effects Observed 
9 + 7% decrease in cells 
31 + 11% increase (normal) 
No effects 
No effects 
No effects 
Reduced growth rates 
0-40% reduction in growth 
Cell degeneration 
Cell degeneration 
30-100% degeneration 
Tumor rejection in some 
animals 
Tumor regression 
Growth inhibition 
Growth inhibition 
45% reduction in growth 
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2.2 Processes of ionizing radiation absorption. 
When trying to understand the development of radiation damage, it is 
convenient to divide the complex chain of events that follow 
absorption of high-energy radiation in living organisms into four 
temporal stages. 
I. During the first or physical stage after absorption of radiation 
energy is transferred. This process leads mainly to molecular 
.excitations and ionizations. The absorption of electromagnetic 
radiation proceeds by three specific mechanisms: (a) the · 
photoelectric effect, (b) Compton effect and (c) pair production. 
The relative likelihood of each mechanism occurring depends on 
the energy of the quantum of radiation. 
(a) Photoelectric effect. 
In this process the incident photon transfers all of its 
energy to an atomic electron. The initial kinetic energy of 
the electron (EKin) is equal to the quantum energy (hf) 
minus the electron•s binding energy A: 
E . = hf - A K1n 
The probability that this process wi 11 occur is highest when 
the energy of the quantum coincides with the binding energy 
of the electron emitted. 
(b) Compton effect. 
In the Compton interaction, in contrast to the photoelectric 
effect, only a part of the energy of the incident quantum is 
transferred to the electron. This reduces the energy of the 
scattered quantum and therefore increases its wavelength. 
In addition the quantum changes its direction. The angle at 
which the electron is -ejected compared to the incident 
direction of the photon, depends on the amount of energy 
- 10 -
transferred to the electron. This energy is not necessarily 
large, for a 10 KeV photon always retains at least 95% of 
its initial energy. 
(c) Pair production. 
This interaction process becomes significant at quantum 
energies exceeding 1 MeV, and consists of the generation of 
an electron-positron pair, by an interaction with nuclear 
fields. The sum of the kinetic energies of the electron and 
the positron is equal to the energy of the quantum less 
twice the rest energy E0 of an electron of rest mass m0 . 
2 (E0 = m0C = 0.51 Mev, 
Ee+ + Ee- = hf - 1.02 MeV) 
The energy (hf- 2 m0 c
2) can be equally divided between the 
two particles with formation of an electron-positron pair. 
This process demonstrates the direct conversion of energy to 
mass, but it must occur in the presence of a third body, 
usually a nucleus. Conservation of momentum and energy are 
maintained by this reaction. This stage occurs very 
rapidly, in about 1o-13s. 
II. The second or physico-chemical stage may consist of a single 
reaction or a complex succession of reactions. The molecular 
excitations and ionizations are extremely unstable and promptly 
undergo secondary reactions, either spontaneously or by.collision 
with other molecules in their vicinity. About 1o- 10s is required 
for the physico-chemical stage. 
III. The third or chemical stage, which takes about 10-6s, is 
associated with chemical changes due to the breakage of bonds. 
If the chain of events, initiated by the absorption of radiation, 
results from direct hits on target molecules within the cell, it 
is possible that the atoms of the components of biological 
molecules could be ionized or excited. This wou1d initiate a 
- 11 -
chain of events leading to changes in the nucleic acids, 
macromolecules within membranes, enzymes and other constituents, 
which may also be damaged by radiation (18, 55). This is the 
so-called direct action of radiation or the direct effect (Fig 
2.1). 
Alternatively, the radiation may interact with atoms or molecules 
in the cell to produce free radicals which are able to diffuse 
far enough to reach and damage critical targets. This indirect 
action theory proposes that radiant energy exerts its effect by 
producing free radicals within cells, according to the following 
sequence. Absorbed radiant energy leads to the radiolysis of 
cell water and the formation of the ionized water molecules H2o+ 
and H2o-. These dissociate to form the free radicals H. and oH·. 
Free radicals can be defined as atoms or groups of atoms having 
an odd (unpaired) number of electrons that may enter into 
chemical-bond formation, which in turn initiate a chain of 
reactions with themselves, their own reaction products and tissue 
water to form other radicals such as H02 and o; 
Time 
10 -13 s 
10-10 s 
10·6 s 
Seconds to 
many years 
i 
Physical 
stage 
Phys. -chem. 
stage 
Chemical 
stage 
Biological 
stage 
- 12 -
Direct effect 
energy absorption 
in biomolecules 
Excited and 
ionized molecules 
Intermolecular 
energy transfer 
/ 
Indirect effect 
energy absorption 
in environment 
+ Excited and 
ionized molecules 
Rearrangement 
Reaction with ~ Primary lesions ._ ____ ;__ _____ Diffusible radicals 
biomolecules 
1 
Intramolecular Reaction with 
energy transfer biomolecules 
~Bioradlcals ~ 
I . Secondary react1ons 
~ 
Molecular alterations 
..-------- -------. 
Genetic alterations Alterations of cell structures 
~ / 
Metabolic alterations 
/~. 
Cell damage repaired Degenerative altera-
(cell survivers) tions of cells 
(cell death) 
d . ff A d' '~k Del aye somat1c e ects .._ cute ra 1at1on SIC ness 
-- . / 
Mutation Death of organism 
Fig 2.1 Direct and Indirect Effects of Radiation in living matter. 
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IV. Ultimately, in the biological state these free radicals can 
2.2.1. 
interact with critical components, such as membrane bound 
molecules, nucleic acids and enzymes. Following this sequence, a 
crucial biochemical change can take place, causing cell damage or 
death (56, 57). The transfer of energy to a target atom or 
molecule from the incident source of radiation energy occurs 
within very small fractions of a second, yet its biological 
effect may not become apparent for minutes or even decades. 
Radiation therefore can have latent sequelae. During this latent 
period, it must be assumed that sequential reactions are 
occurring that ultimately exert a detectable functional, 
biochemical or morphological effect (58). 
Molecular changes occurring in an organism may cause alterations 
in the system which is passing through the 11 biological stage" 
(Fig 2.1), finally leading to the development of the observed 
biological effect (59). 
The primary processes of radiation absorption can cause small but 
significant injuries in the organism as a whole. However, the 
type and magnitude of the damage can depend very much on whether 
the defect can be repaired (60, 61) or whether the metabolism in 
attempting to operate under these perturbed conditions, tends to 
amplify the damage (62, 63). 
Target theory 
The dose-response curve can be analyzed in terms of the target 
theory. It assumes that the events occurring as a result of the 
irradiation, named the "hits", happen independently. Therefore, 
the Poisson distribution (P(n)) may be used to calculate the 
probability that a particular member of the irradiated sample 
will receive n 11 hits". 
Probability of hits = P(n) = (vD)n exp(-vD) 
n! 
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where v is the volume of the target and D is the radiation dose. 
It is assumed that if a given member of the sample popuJation is 
inactivated by n hits, then all the members of the sample that 
receive fewer than n hits will survive and are presumed to be 
unaffected by the radiation. Therefore, the probability of 
survival (Nsur/N0 ) (where Nsur is the number which survive and N0 
the initial number in the population) is: 
Nsur 
---- = P(O)+ ... P(n-1) 
No 
= exp(-vD)(1 + vD + 
K 
= exp(-vD)n~ 1 (~~) 
yO +".. vD l ( )2 ~-1
2! n-11! 
N 
If n = 1, then sur = exp(-vD) 
No 
Therefore, if (ln ~sur) is plotted versus D, the target volume is 
0 
the slope of the line. 
Since D = 1 when (Nsur/N0 ) = 37% or 1/e, 
the target volume is also the reciprocal of o37 , the dose at 
which about 37% of the targets survive, or are unaffected. 
It is possible to derive expressions for systems with several 
targets. This is the case in which a given member of the sample 
must receive n hits on each of several different sensitive 
volumes within the given member in order to be inactivated. 
However, such situations are complicated and the inherent 
variations in the dose-response curves limit the accurate 
interpretation of the equations. 
Nsur 
- = 1 - W(D) No 
where W(D) is the probability that a dose D will produce an 
effect. The value of W(D) will range from 0 to 1 and clearly 
each hit will increase the value of W(D). 
W(D) = ~ dO 
- 15 -
From this expression the variances are derived. 
m1 = 6 DW(D)dD 
- 2 and a - m2 - m1 
The steepness of the dose-response curve may then be defined as: 
S = m2/a 2 1 
From this, it follows that n, the average number of hits needed 
to produce an effect must be ljmited by the condition that 
n ~ s 
Thus it is possible to determine the value of S from experiment, 
which gives the least number of hits required to describe the 
effect of the radiation. Most of the experimental evidence 
suggests that the dominant processes are single hit events. 
The dose-response curve is then obtained by plotting the survival 
fraction as a function of the amount of radiation incident upon 
the sample. An example is given in Fig (2.2). 
The basic idea of the target theory can be expressed as an 
attempt to determine the number of 11 hits 11 per unit volume when 
ionizing radiation interacts with living matter. From this one 
derives the volume of the target and therefore the size of the 
radiation sensitive substructures of the biological system {39). 
These indicate that in the case of ionizing radiation a 11 hit 11 
depends on a single transfer to the biological system of a 
cet~ta in amount of energy, the magnitude of which depends on the 
kind of damage and the system irradiated (64, 65). 
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Fig 2.2 The dose response curve. 
2.2.2. 
The notion of the target must not be overinterpreted. Damage to 
the 11 target 11 by 11 hits" from the radiation is certainly a reality, 
but action also occurs due to radiation effects elsewhere. This 
situation has led to the hypothesis of indirect effects in 
solutions by the radiation. 
Radiolysis of water and the primary reactions of the products. 
Exposure to ionizing radiation leads to the formation of highly 
reactive species in most solvents. In water ftbsorption of 
radiation energy leads primarily to ionised water molecules 
(ionization potential 12.56 eV): 
H20 + H20+ + e- (2.1) 
-The electron may become stabilized as a hydrated electron, eaq 
and in this form it can produce effects far away from its point 
of origin because it can diffuse through the water for 
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considerable distances. The positive ion formed in this process 
can lead.to the formation of OH" radicals by: 
(2.2) 
and the reaction of electrons with water molecules can lead to 
the production of H" radicals 
e- + H20 + OH- + H" (2.3) 
The H" and OH" species as well are formed directly by excitation 
(about 7 eV) and dissociation of a water molecule 
(2.4) 
Although a pH dependence of the yields of water radicals might be 
expected on the basis of these reactions, it is only significant 
at very high or very low pH values. In the region where 
3 < pH < 10, the G-values (the number of products formed per 100 
eV of absorbed radiation energy) for the above products are: 
Recombination processes lead to the formation of H2, H2o2 and 
H20. 
High linear energy transfer (LET) radiation, where the local 
concentration of water radicals is high, will favour 
recombination, and therefore the formation of H2, H20 and H2o2 at 
the expense of radical products. An increase in the yield of H2 
and H2o2 with increasing LET, and a consequent decrease in 
indirect action has been observed. 
H" + ow + H20 (2.5) 
H" +H" + H2 (2.6) 
HO" + HO" + H2o2 (2. 7) 
The formation of free radicals during redox reactions is crucial 
because of the ubiquitous nature of these processes in living 
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cells. The two following equations represent the extension of 
the description of radiolysis of water, when oxygen is present: 
(2.9) 
(2.10) 
The free radicals may subsequently react with some critical 
component if the cell, which may include membranes DNA, RNA, 
proteins and induce crosslinks, scission and other rearrangements 
(18, 66, 67) (Fig 2.3). 
Mernbrane injuries 
membrane surface 
proteins 
J 
Fig 2.3 Free radical damage to membranes. 
2.3 Nature of interactions of magnetic fields with biomolecular 
systems. 
Magnetic fields disturb atomic and molecular energy distributions and 
wave functions and thus introduce certain spatial and directional 
asymmetries in electron currents. The extent of these distortions 
depends on quantum mechanical and thermodynamic considerations. The 
energy absorbed by the biomolecular system from the sources goes into 
excitation energy, kinetic energy and electromagnetic potential 
energy, part of which is dissipated in the form of heat. 
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The distortions caused by magnetic fields give rise in part to elastic 
forces (stress) associated with binding forces of the living organism, 
comprising the liquid and the biomolecules (31, 68). The 
magnetostriction does not affect the center of mass motion of the 
body, but it does affect the shape of the body and even in certain 
circumstances its stability. Destruction of cells may occur if the 
tensile strength of cell membranes is exceeded. 
The magnetization energy or interaction energy (W) of a magnetic field 
(B') with biological molecules of diamagnetic susceptibility is given 
as: 
W = -l bM.B'dv (2.11) 
where the volume integral is taken over the molecule and where M is 
the net magnetic dipole moment (both diamagnetic and paramagnetic) 
induced in the body per unit volume. For fields up to 2 Tesla (T) the 
magnetization energy for small structures is in the order of 10-19 to 
Io-21 Joule (J). Molecules and some organized cellular structures 
have magnetic susceptibilities that vary with direction, for example 
retinal rods (69), DNA liquid crystals and sickled red cells (70). 
If this magnetic anisotropy in susceptibility is sufficiently large, 
then a significant torque can be expected. Any resulting torque or 
force will depend on the orientation, difference of the 
susceptibilities between body and surroundings and the square of the 
magnitude of magnetic field. 
The traction t on an arbitrary element of the body is given by the 
following expression: 
t = c~+t{b2-b 1 >> R (R.n) - 1 c~ + b2)H2 n 
where n is the unit normal {external) vector of the molecules or 
subcellular units and b1 and b2 are the rates of change in ~ with 
respect to strains parallel and perpendicular to A respectively. It 
I 
has been suggested that magnetic fields may affect cell division (71). 
Cell division is preceded by a DNA replication process which involves 
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many biochemical reactions requiring extremely complex arrangements of 
molecular and vital cellular components (72, 73). If these components 
have anisotropic magnetic susceptibilities, then not only the 
rotational diffusion rate, but also the relative orientation of these 
vital biomolecules would be altered. This may, for example, affect 
the transmembrane permeability, cellular replication and thermodynamic 
processes (See appendix A). Electron transfers are commonplace in 
chemical reactions. These reactions generally involve the formation 
of transient radical ion pairs. 
Nonadiabatic electron transfers result in formation of a correlated 
radical ion pair. The magnetic external perturbations of the radical 
pairs• spin state may modify the course of some biochemical reactions, 
as well as various electrochemical processes resulting in a variety of 
biomagnetic effects (74, 75, 76). 
2.4 Some aspects of the biology of neoplasms. 
The word oncology is derived from two Greek words, oncos, meaning a 
mass or a tumour and logos, meaning a dissertation or a special study. 
Thus oncology is the study of tumours or neoplasia and neoplasm 
literally means new growth and the new growth is a neoplasm. In this 
thesis, the terms tumour, neoplasm and new growth will be used 
synonymously. Briefly, a tumour may be defined as an abnormal mass of 
tissue or an abnormal cell population with a capacity for progressive 
growth (77). The origins of a malignant cell population as well as 
the etiology of a particular type of cancer may very between different 
tissues within any given species. Nevertheless, two characteristic 
features which appear to be universally associated with all neoplastic 
cells are uncontrolled cell proliferation and possibly restricted or 
aberrant cell differentiation (78). These two phenotypes are not 
mutually exclusive and may arise by successive somatic cell mutations 
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and by epigenetic changes in the immediate environment surrounding a 
potential target stem cell. Abnormalities in the control of gene 
expression may be a contributing factor in the transformation process 
as a result of these mutational and/or epigenetic alterations. Many 
observations suggest that malignant transformation is the result 
either of abnormal expression of genes normally present in the genome 
of the host cell, or of some modification of an endogenous gene or 
genes (79). In either event, gene products such as transforming 
proteins are produced that alter cell differentiation, replicative 
activity and inter-cellular behaviour (80, 81). Tumour cells have a 
clonal origin and are converted to an "initiated" cell, which is a 
rather stable alteration in the genome (82). This may be true for 
those genes regulating cell growth and differentation of stem cells in 
tissues, which are undergoing regeneration or renewal. These 
processes are probably controlled by a complex interplay of various 
growth factors and morphogenic and differentiation - inducing factors. 
Morever, the growth and differentation of any particular population of 
cells does not proceed in an isolated environment in vivo, but is 
dependent upon appropriate heterotypic cell-cell interactions (83, 
84). 
2.4.1. 
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Attributes of transformed tumour cells. 
The intracellular, presumably molecular, event or events that 
bring about the conversion of normal cells to cancer cells is of 
course a critical issue that is still under investigation. But 
whatever is involved the phenotype of the tumour cells differs in 
many ways from the normal (85). These differences can be 
arbitrarily divided into: 
(1) altered growth properties; (2) morphological changes; (3) 
karyotypic changes; (4) antigenic changes; (5) altered cell 
surface characteristics and (6) metabolic deviations. 
(1) Altered growth properties. 
Unregulated proliferation in a fundamental feature of all 
neoplastic cells. There is a loss of response to regulatory 
controls of disturbance in the homeostatic mechanism which 
controls the cell m~ss of a tissue (86). Failure to mature 
may play as important a role in the altered growth of cancer 
as unregulated proliferation. When cells fail to mature, 
they live much longer than normal cells because the former 
have not had a terminal differentiation. 
(2) Morphological changes. 
Lack of differentiation or anaplasia is marked by a number 
of morphological and functional changes. Both the cells and 
their nuclei characteristically display pleomorphism 
(variation in size and shape). Cells may be found that are 
many times larger than their neighbours and other cells may 
be extremely small and appear primitive. Characteristically, 
the nuclei contain an abundance of DNA and are extremely 
dark staining (hyperchromatic}. The nuclei are 
disproportionately large for the cell and the 
nuclear-cytoplasmic size ratio may approach 1:1 instead of 
the normal 1:4 or 1:6. Electron microscopy shows 
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accentuation of the nuclear chromatin in clumps along the 
nuclear membrane, simplification of the rough endoplasmic 
reticulum, an increase of free ribosomes, and greater 
pleomorphism of the mitochondria. 
Oxygen diffuses out from the capillaries and is avidly 
consumed by act.ive metabo 1 i c activity of tumour ce 11 s. So 
it is depleted within a distance of 150-200 ~m from the 
capillary (6, 87). Hence cells lying more than about 150 ~m 
away from the capillary exist in hypoxic and anoxic states 
with progressive swelling of mitochondria, Golgi 
apparatus and lysosomes. This is concomitant with falling 
pH due to glycolysis, lactate accumulation and breakdown of 
phosphate esters (88). By histological examination of 
sections, it is possible to distinguish only two classes of 
cells namely, those which appear to be proliferating 
healthily and those which are dead or dying. In the anoxic 
stage necrosis of the cells refers to the sum of the 
morphological changes occurring within dead cells in tumour 
tissue. These changes are caused by depletion of oxygen 
supply and nutrients (89), with consequent mitochondrial 
dysfunction (lack of oxidative phosphorylation and ATP 
generation), development of profound disturbances in 
membrane function and rupture of lysosomes. 
(3) Karyotypic changes. 
The malignant cells of most types of tumours have 
chromosomal abnormalities. Most of the chromosomal 
alterations only became evident with the advent of the newer 
high resolution banding techniques that now reveal 1200 or 
more specific bands within the karyotype. 
As mentioned in Chapter 1, in many forms of cancer the 
chromosomal abnormality is related to certain genes, called 
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oncogenes, through rearrangements of the DNA code, which 
permit these genes to be expressed and therefore the 
mechanism of neoplastic transformation assumes a stable 
alteration in gene expression (90, 91). 
In 1911, Peyton Rous discovered the Rous sarcoma virus 
(RSV), a filterable agent that could produce sarcomas in 
inoculated chickens (92). However, it was not until many 
decades later that the gene responsible for tumour induction 
by the Rous virus was identified in the viral genome. In 
fact the product of a single gene appeared to be both 
necessary and sufficient for tumour formation. This was a 
considerable advance in understanding cancer. It came as a 
great surprise when it was discovered that the transforming 
gene, subsequently termed src, had a homologue in normal 
uninfected cells and that this cellular gene, termed C-src, 
was conserved not only in the chicken genome, but in the 
genome of all ~ther vertebrates as well. This work provided 
the first evidence for the presence of potential 
transforming genes (oncogenes) in normal cells (93, 94). 
Several such oncogenes, caused by acute transforming 
retroviruses have been discovered (Table 2.3). The oncogene 
is that part of the virus genetically responsible for its 
ability to cause cancer. These genes are not essential for 
the growth of the viruses that carry them. However, this 
advance in the investigation of oncogenic retrovirus did not 
come from a study of the rapidly transforming vi ruses s'uch 
as RSV, but rather from work on tumour viruses with long 
latent periods, such as the avian leukosis viruses (ALV) of 
chickens. These viruses were shown to cause tumours by 
activation of a cellular oncogene (95). 
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There are at least three different pathways for the 
initiation of neoplastic transformation: the insertion and 
expression of exogenous viral oncogenes, a change in the 
expression of a host gene induced by the insertion of viral 
DNA in, or adjacent to it, and non-virally mediated change 
in the expression of an endogenous cancer gene. 
/ 
In addition to the specific karyotypic alterations in 
certain tumours, a wide range of non-specific numerical and 
structural chromosomal abnormalities are frequently present 
in solid neoplasms (96). These presumably represent 
secondary changes acquired in the course of tumour 
progression, related to some altered biological behaviour 
(97). 
TABLE 2.3: 
Retroviral 
oncogene 
v-src 
v-fps 
v-fes 
v-yes 
v-ros 
v-myc 
v-erb-A+B 
v~myb 
v-rel 
v-mos 
v-abl 
v-fos 
v-raf 
v-Ha-ras 
v-Ki-ras 
v-fms 
v-sis 
v-fgr 
v-mil 
v-ets 
v-ski 
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RETROVIRAL ONCOGENES. 
Name and origin of virus Species 
of origin 
Rous sarcoma Chicken 
Fujinami sarcoma Chicken 
Snyder-Theilen feline sarcoma Cat 
Yamaguchi sarcoma Chicken 
Rochester 2 sarcoma Chicken 
Myelocytomatosis, strain MC29 Chicken 
Avian erythroblastosis Chicken 
Avian myeloblastosis Chicken 
Reticuloendotheliosis, Turkey 
strain T. 
Moloney sarcoma Mouse 
Abelson leukemia Mouse/cat 
FBJ murine osteosarcoma Mouse 
Recovered 3611 Mouse 
Harvey rat sarcoma Rat/mouse 
Kirsten rat sarcoma Rat 
SM feline sarcoma Cat 
Simian sarcoma Woolly monkey/ 
cat 
Gardner-Rasheed sarcoma Cat 
MH2 Chicken 
E26 Chicken 
Sloan-Kettering Chicken 
Tumour 
Sarcoma 
Sarcoma 
Sarcoma 
Sarcoma 
Sarcoma 
Carcinoma, Sarcoma, 
Myelocytoma 
Erythroleukemia 
Myeloblastic leukemi'a 
Lymphatic leukemia 
Sarcoma 
B-cell lymphoma 
Sarcoma 
Fibrosarcoma 
Sarcoma and 
erythroleukemia 
Sarcoma and 
erythroleukemia 
Sarcoma 
Sarcoma 
Sarcoma 
Sarcoma/carcinoma 
Erythroid Leukemia 
Sarcoma 
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(4) Antigenic changes. 
Cancer cells, when transformed in vitro or in vivo by 
carcinogenic agents express a range of antigens, most of 
which are found in normal cells. In addition they express a 
great many tumour associated antigens that may or may not be 
present in normal cells, but in any event are more abundant 
in tumour cells. These tumour-associated antigens, 
so-called "markers" of the tumour, can sometimes be used 
with appropriate immunocytochemical procedures to identify 
tumour cells histologically. Some tumour markers are 
produced in large quantities and released into the blood in 
sufficient amounts to be detectable by sensitive 
immunological assays, and thus provide clinical evidence of 
the presence of a neoplasm. 
(5) Altered cell surface characteristics. 
Extracellular regulators of many types probably interact 
with the cell membrane and then cytop 1 asmi c media tors appe<!r 
to transmit signals (98) from the membrane to the nucleus, 
where perhaps they control DNA-binding proteins. The cell 
membrane, therefore, is implicated in playing a critical 
role in cell proliferation (99). A number of alterations, 
have been shown in the plasma membranes of tumour cells and 
include the following: A loss, diminution, or in some cases 
acquisition, of such surface specialisations as microvilli 
and pseudopodia. 
Alterations in cell junctions 
Inconstant cytoskeletal alterations 
Alterations in surface electric charge 
Changes in surface-associated glycoproteins and 
proteins, particularly enzymes affecting membrane 
transport. 
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Changes in glycolipids and lipids affecting 
permeability, surface receptors and surface antigens. 
Enhanced lectin agglutinability. 
Changes in responsiveness to inhibitory and stimulatory 
putative growth factors. 
Alterations of surface-associated and intracellular 
ions. 
The above represents a very incomplete listing, but it 
indicates the scope of the changes. 
Cell surface and membrane changes indicate that there are 
many deviations from normal that are usually found in tumour 
cells. Collectively these alterations give some explanation 
of the attributes of the malignant phenotype in the tumour 
cells (100). 
(6) The metabolism of tumour cells 
The stimulating and inhibiting influence of hormones on cell 
proliferation is known. Hormones may influence cell 
proliferation via the cyclic AMP/adenylate cyclase system 
(101, 102), (Fig 2.4). 
i 
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cAMP as a second messenger conveying the signal received from the 
agonist on the plasma membrane to the responsive enzymes within the 
cell. 
Adenylate cyclase is located on the cell membrane and is 
involved in the formation of cAMP from ATP {Fig 2.5). 
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Cyclic AMP is an intracellular messenger (103). For example 
hormones that bind to membrane receptors assert their 
intracellular actions by modifying cAMP levels. It is 
therefore interesting that reduced cAMP is commonly found in 
transformed cells, suggesting lack of regulatory signals 
involved in control of cell growth and division. Underlying 
the lower levels of cAMP. are reductions in membrane 
adenylate cyclase and increase in the cyclic nucleotide 
phosphodiesterase involved in its breakdown (104). 
In the 1920s Warburg called attention to what he construed 
to be a fundamental metabolic alteration in cancer cells, 
namely an unusually high rate of anaerobic metabolism even 
in the presence of oxygen, so-called aerobic glycolysis 
(105). It is now recognized that this metabolic change 
reflects rapid growth of cells (106). There is increased 
synthesis of cellular constituents required for cell. 
division. There is some conjecture as to the importance of 
glycolysis in rapidly dividing tissues, and includes the 
following points: 
(1) The rapid proliferation of the cells may disorganize their 
blood supply to such an extent that sufficient oxygen cannot 
reach all the cells and anaerobic glycolysis is necessary to 
provide the energy for cell growth and division (107). 
Nonetheless, it should be borne in mind that some blood 
supply will be essential to provide glucose for the 
glycolytic process (108). 
(2) In rapidly growing and dividing cells, several essential 
macromolecules need to be produced, for example DNA, RNA, 
protein, polysaccharides and lipids. It has been suggested 
that a high capacity of glycolysis is necessary to maintain · 
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high concentrations of metabolic intermediates that can be 
used as precursors for macromolecular synthesis {109). 
{3) The change towards a greater glycolytic potential is also 
accompanied by changes in isoenzyme patterns that are 
similar to those found in fetal tissue. It is possible that 
the genetic changes, that are ultimately responsible for the 
cause of the tumour, may coincidentally cause a change to a 
cell resulting in a greater glycolytic capacity. 
One obvious feature of the tumour cells is that the norma·l 
regulation of cell growth and division is impaired or even 
lost {110). 
2.5 Energy and Adenosine Triphosphate 
2.5.1 
The importance of energy to metabolic processes in heterotrophic 
organisms, where the nucleoside phosphate pool plays a central role in 
the transformation of energy from exergonic to endergonic processes, 
has been extensively reviewed by a number of authors {111, 112, 113). 
It i~ my intention, therefore, to discuss briefly the mechanism by 
which the cell derives its energy with special reference to adenosine 
triphosphate. Emphasis will however be placed on those areas which 
are of major importance to the present investigation. 
Fuels and the source of cellular energy 
The enzyme-catalysed biochemical reactions constituting 
metabolism include some in which large molecules are broken into 
smaller ones and others in which small molecules are used for the 
synthesis of larger and more complex molecules. The enzymatic 
breakdown or catabolism of cellular fuels involves two major 
phases in mammals. Firstly there is digestion in the alimentary 
canal which serves to break the large organic molecules present 
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in food into smaller molecules~ which can be absorbed, 
distributed throughout the organism, and enter cells in the 
various tissues. Secondly the absorbed molecules are themselves 
further degraded in the individual cells of the body. Some of 
the chemical energy present in these compounds is transferred to 
other molecules, notably ATP which can be used directly to 
provide energy (114, 115, 116). In addition, the same products 
of digestion are used to synthesise new molecules in anabolic 
processes. These are required for a variety of purposes: to 
achieve growth and repair of the organism, to replace molecules 
of the organism which have broken down and to replenish the 
stores of fuel which subsequently undergo catabolism (117). The 
important energy-yielding (for example ATP producing) processes 
in the degradation of organic molecules are oxidative reactions 
with molecular oxygen acting as the final oxidizing agent. The 
oxidative processes leading most directly to ATP synthesis, 
namely the tricarboxylic acid cycle, electron transfer and 
oxidative phosphorylation Fig (2.6) have been extensively studied 
by many authors (118, 119, 120, 121). 
- 33 -
Fig 2.6 Major pathways for ATP synthesis 
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Through the generation of ATP, the energy originally derived from 
carbohydrates and fats is redistributed as a conveniently 
packaged form of free energy, that is easily released (122, 123). 
Roughly 109 molecules of ATP are in solution throughout the 
intracellular space of a typical cell. The energetically 
favourable hydrolysis back to AOP and phosphate provides the 
driving energy for a variety of energetically non-equilibrium 
reactions (See Appendix A). The yield of ATP from various fuels 
under aerobic and anaerobic conditions is shown in Table 2.4. 
TABLE 2.4: THE YIELD OF ATP FROM VARIOUS FUELS. 
Fuel Conditions ATP yield (mol) per 
mol of fuel utilized 
Glucose Aerobic, complete oxidation 38 
Glucose Anaerobic, conversion to lactate 2 
Glycogen Aerobic, complete oxidation 39 
Glycogen Anaerobici conversion to lactate 3 
Palmitate Aerobic, complete oxidation 1~ 
Acetate Aerobic, complete oxidation 24 
2.5.2 The thermodynamic role of ATP in metabolism. 
Adenosine-5'-triphosphate (ATP) is synthesised from AOP and 
inorganic phosphate (Pi) during the catabolism of fuels such 
glucose, glycogen or fats. It is used in such processes as 
muscle contraction, active transport, repair mechanism after 
metabolic injuries, biosynthesis, etc (124, 125). 
The hydrolysis of ATP at pH 7.4 and in the presence of Mg2+ can 
be represented as follows: 
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0.88 MgATP2-+0.014H ATP3-+0.106 ATP4-+H20 + 0.40 MgADP-+ 
0.06 H ADP2-+0.54 AOP3-+0.04 MgHP04+0.10H2Po4-+0.86HP04
2
-+ 
2+ + 0.44 Mg +0.85H • 
The standard free energy (~G) of hydrolysis of ATP, measured at 
25°C and pH 7.4, is -8.8Kcal (-36.8 KJ) per mole. 
The cells utilize the free energy available from phosphate 
transfers involving ATP to ensure that certain reactions are 
energetically favourable (126). 
The reason for the relatively large.change in free energy when 
ATP is hydrolyzed under standard conditions is that the products 
of the reaction (ADP and Pi) are much more stable than ATP at or 
around pH 7.4. At least three factors contribute to this 
increased stability (Fig 2.7). 
(1) Resonance stability 
Compounds are more stable when their bonding electrons are 
distributed over more than one covalent bond (delocalization). 
This can be indicated by consideration of a number of extreme 
structures (resonance or canonical forms) in which the electrons 
are delocalized with the actual structure in them considered to 
be intermediate between these forms. 
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In the phosphate ion all the oxygen atoms are equivalent, so that 
the actual structure is intermediate between the following 
resonance forms: 
0 
II 
o--p-o- =:; 
I 
o-
(2) Charge repulsion 
o-
1 
o--P=O 
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o-
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At physiological hydrogen ion concentrations the phosphorus atoms 
of ATP are bound to negatively charged oxygen atoms. 
Repulsion between these charges causes strain in the molecule 
which is relieved on hydrolysis when the charges can separate. 
(3) · Ionization 
On hydrolysis of ATP two new acid groups occur: 
H,O + 1.JSo--H ~ ~ ~ -
H N ~H. CH2-0- P-O-P-O-P-0 -. 
. . I I I 
o- o- o-
o 
H HO OH H 
&}-H ~ ~ ~ 
H N N~H CH2-0 -P-O-P-O+ HO-P-OH 
I I I o- o- o-
o 
H HO OH H 
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At pH 7.4 one of these groups is partly ionized according to the 
equation: 
0 
II 
HO-P-OH ~ 
I 
o-
0 
II 
HO-r-o- + H• 
I 
o-
This ionization has a large negative ~G which contributes to the 
overall ~G for ATP hydrolysis. 
Factors·2 (charge repulsion) and 3 (ionization) suggest that the 
~G of ATP hydrolysis will be highly pH dependent. That this is 
the case is seen by comparing the value of ~G near pH = 0 
(-1.25 KJ/mole) with that at pH= 7.4 (-36.8 KJ/mole). 
The interplay betw~en various high-energy phosphates is related 
to the nuc~eoside phosphate pool. Exergonic processes, such as 
the oxidation of fuels, drive the phosphorylation of ADP from 
ATP. Part of the ATP is used to phosphorylate nucleoside mono 
phosphates to form nucleoside diphosphates and to phosphorylate 
nucleoside diphosphates to form nucleoside triphosphates. 
ATP is used in rephosphorylation of other kinds of nucleotides. 
Thus the expenditure of any other high-energy phosphate for 
endergonic purposes, such as the biosynthetic formation of tissue 
components, and anabolic processes in repairing damage after 
metabolic injuries (127, 128, 129) is equivalent to the 
conversion of ADP to ATP. This implies the ultimate result in 
each case is the replenishment of the high-energy phosphates (Fig 
2.8) by highly exergonic processes coupled to the phosphorylation 
of ADP (130, 131). 
- 39 -
OXIDIZED lATPI · TISSUE 
PRODUCTS COMPONENTS 
various highly various 
uergonic endergonic 
processes P, processes 
' 
' ' FUELS JADPI ' PRECURSORS 
Fig 2.8 The nucleoside phosphate pool 
2.5.3 
Acknowledging that certain reactions involving ATP are localized 
in certain regions of the cell is not proof of a functional 
compartmentalisation. The effects of a biochemical change in one 
region of the cell are felt very rapidly throughout the ce11, for 
these reactions behave like a functional syncitium. 
Intermediary metabolismof carbohydrates. 
The metabolism of carbohydrates may be subdivided as follbws: 
(1) Glycolysis: The oxidation of glucose or glycogen to pyruvate and 
1 actate by the Embden-r~eyerhof pathway. 
(2) Glycogenesis: The synthesis of glycogen from glucose. 
(3) Glycogenolysis: The breakdown of glycogen. 
(4) The oxidation of pyruvate to acetyl CoA: This is the necessary 
step prior to the entrance of the products of glycolysis into the 
citric acid cycle, which is the final common pathway for the 
oxidation of carbohydrates, fat and protein. 
2 ._5 .4 
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(5) The hexose monophosphate shunt {pentose phosphate pathway): An 
alternative pathway to the Embden-Meyerhof pathway for the 
oxidation of glucose. Its primary function is the synthesis of . 
important intermediates such as NADPH and ribose. 
(6) Gluconeogenesis: The formation of glucose or glycogen from 
noncarbohydrate sources. 
The hexose monophosphate shunt. 
It is appropriate to consider this pathway in more detail, 
because it is related to some of the biochemical parameters that 
were investigated in this work under normoxic and hypoxic 
conditions in rodent tumours, in response to radiation. The 
major functions of the h~xose monophosphate shunt are to provide 
NADPH for reductive syntheses outside the mitochondria and to 
provide ribose for nucleic acid synthesis (132, 133). 
The sequence of reactions of the shunt pathway may be 
conveniently divided into two phases. In the first, glucose 
6-phosphate undergoes dehydrogenation and decarboxylation to give 
ribulose-5-phosphate. Dehydrogenation of glucose 6-phosphate to 
6-phosphogluconate occurs via the formation of 6-phosphogluconate 
catalyzed by action of glucose 6-phosphate dehydrogenase, an 
NADP-dependent enzyme (134). The hydrolysis of 
6-phosphogluconolactone is accomplished by the enzyme 
gluconolactone hydrolase. A second oxidative step is catalyzed 
by 6-phosphogluconate dehydrogenase, which also requires NADP+ as 
hydrogen acceptor (Fig 2.9). 
In the second phase, ribulose 5-phosphate is converted back to 
glucose 6-phosphate through fructose 6-phosphate by a series of 
reactions involving mainly 2 enzymes: transketolase and 
transaldolase. 
NAOP + NAOPH+H + H20 
Mg2+, Mn2+ ~Mg20/ .--------------,Jb or Ca2• I ~0-Giucose-6-Phosphate ~  lliJ' 6-Phosphogluconolactone 
- Glucose 6-P 
~Ca2• _ ---'=------1•~ ( 6-Phosphogluconate ·I 
Glueonolactone 
Hydrolase Dehydrogenase 
Ribose S·Phosphate 
11-Phosphoglueonate 
Dehydrogenase 
NAOP+ 
+H+ 
1 
I Ketoisomerase I I I I Enediol form Ribose-5-phosphate ~ 7 · 3-Keto-6-phosphogluconate. 
I Ribose-S:P~osphate I 
Phospho· 
transferase 
[Ribose-1-phosphate ) 
ATP 
Fig 2.9 The hexose monophosphate shunt. 
Ribulose S·Phosphate 
3·Epimerase 
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THIAMIN-P2 
Mg2• 
[ Sedoheptulose-7-phosphate I 
1· Gl;~~raldehyde-3-phosphate .I 
~ 
...... 
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A summary of the total reaction of the hexose monophosphate 
pathway may be represented as: 
3 Glucose 6-P + 6NADP+ .+ 3C02+2 Glucose 6-P + 
Glyceraldehyde 3P + 6NADPH + 6H+ 
The metabolic significance of the hexose monophosphate shunt. 
Most of the tissues in which the pathway is active use NADPH from 
the shunt in the synthesis of fatty acids or steroids and in the 
synthesis of amino acids via glutamate dehydrogenase. It is 
probable that the presence of active lipogenesis, or of a system 
which utilizes NADPH, stimulates an active degradation of glucose 
via the shunt pathway. 
The hexose monophosphate shunt provides NADPH for the reduction 
of oxidized glutathione (G-S-S-G) to reduced glutathione (2GSH), 
catalysed by glutathione reductase (135). 
Glutathione 
G-S-S..;G+NADPH+H+ 2GSH+NADP+ 
reductase 
Reduced. glutathione is important in protecting the cell against 
free-radical damage initiated by oxygen radicals. 
For example superoxide can inactivate the damaging superoxide 
radical with production of another toxic species, namely hydrogen 
peroxide 
Superoxide 
dismutase 
2.5.6 
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In turn reduced glutathione removes H2o2 from the cell in a 
reaction catalyzed by glutathione peroxidase. 
Glutathione 
peroxidase 
Then, the oxidized glutathione is reduced with NADPH from the 
pentose phosphate pathway. 
The hexose monophosphate shunt also provides pentoses for 
nucleotide and nucleic acid synthesis (136) (Fig 2.9). 
Source of Reducing Equivalents (NADPH) by Isocitrate 
Dehydrogenase. 
Both in the cytosol and in the mitochondria there is an 
NADP-coupled isocitrate dehydrogenase (Fig 2.10). 
cooe 
I H-C-OH 
I 
eooc-c-H 
I CH 2 I 
cooe 
isocitrate 
NADPCB NADPH 
\. ,) ~ 
ICDH 
cooe 
I C=O 
I CH2 I CH 2 I 
cooe 
a-ketoglutarate 
Fig 2.10 Generation of NADPH by isocitrate dehydrogenase. 
This enzyme catalyzes the same oxidative decarboxylation of 
isocitrate that occurs in cytosol and mitochondria during the 
citric acid cycle. However, in the mitochondria there can be ctn 
alternative or additional reaction which uses NAD as the 
oxidizing agent (137). 
The extra energy liberated (AG = 17.5 KJ/mole) by the 
decarboxylation drives the reaction toward completion, generating 
2.5.7 
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a high {NADPH)/{NADP) ratio. It is of interest to note that 
although some oxidoreductases can utilize both NAD+ and NADP+ as 
electron acceptors, most use exclusively one or the other. As a 
broad generalization oxidoreductases functioning in biosynthetic 
or anabolic processes in mammalian systems {e g fatty acid or 
sterol synthesis) tend to use NADPH as reductant, while those 
functional in degradative or catabolic processes (e g glycolysis 
or fatty acid oxidation) tend to use NAD+ as oxidant. 
The oxidative reactions of the hexose monophosphate shunt, and 
the extramitochondrial isocitrate dehydrogenase reaction appear 
to be a very important route for generating NADPH (138), in 
addition to the malic enzyme (NADP malate dehydrogenase) in the 
biosynthesis of fatty acids (139) {Fig 2.11). 
Glycolytic metabolic intermediates related to mannose residues. 
· D-Mannose in a major constituent of the asparagine linked 
oligoscacharides of eukaryotic glycoproteins (140). The group 
includes plasma proteins and membrane components such as 
acetylcholine receptors {141). 
·The mannose donor for oligosaccharide synthesis in GOP-a mannose, 
which is formed from a-D-mannose-1-P and GTP by action of a 
specific pyrophosphorylase. 
Palmitate 
Fatty acid synthase 
multienzyme complex 
Acetyi·CoA 
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Fig 2.11 NADPH generators: Hexose monophosphate shunt, isocitrate 
dehydrogenase and malate dehydrogenase. 
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Mannose chains, some of which are shown below (Fig 2.12) are 
found in cell membranes. 
Man Man Man Man I I I I 
Ma" Man Man Man Man Man Man Man Man Man 
I I \ I I \ I I \ I 
Man Man Man Man Man Man Man 
"'-.. I '\. / "\./ 
" 
/ 
Man Man Man Man 
I I I 
GlcNAc GlcNAc GlcNAc GlcNAc 
I I I I 
GlcNAc GlcNAc GlcNAc GlcNAc 
I I I I 
Asn Asn Asn Asn 
Fig 2.12 Structures of high mannose chains. Mannose (Man), Glucose (Glc), 
N-acetylglucosarnine (GalNac), Asparagine (Asn). 
Mannose phosphates originate from the glycolytic intermediate 
glucose-6-P through the action of two enzymes, phosphoglucose 
isomerase (PGI) and phosphomannose isomerase (PMI) (142, 143) as 
indicated below in (Fig 2.13). 
H OH 
P-u-glucose 6-phosphate 
PGI 
• • 
H 
HO 
H H 
~mannose+phosphale 
H 
H 
Fig 2.13 Interconversion of glycolytic intermediates by the action of PGI and 
PM I. 
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Phosphomannose mutase (PMM) catalyzes the interconversion of 
mannose-6-P and mannose-1-P (144). 
The glycolytic metabolic intermediate pathway is related to 
mannose residues as represented in (Fig 2.14). It enables 
mannose 6 phosphate to be catabolised through the action of 
phosphomannose isomerase, via the glycolytic pathway (145, 146, 
147). 
Glucose Fructose 
~ ~ 
Glucose 6-P • .,.. _ __..,. Fructose 6-P 
~ t 
Ribulose 5-P 7 6-P-Giuconate • Pyruvate 
Mannose-6-P 
.. 
Mannose-1-P 
TCA cycle 
Fig 2.14 Glycolytic pathway related to mannose residues (TCA = tricarboxylic 
acid cycle) 
2.6. Mitoxantrone an anticancer drug 
There is presently a great deal of interest in combining ionizing radiation 
and anticancer drugs in the laboratory with the aim of providing new 
strategies in the clinic. It became apparent during the course of this 
investigation that an agent was required that would inhibit the increase in 
energy production seen after irradiation (Chapter 5). Neri et al (148) 
reported that mitoxantrone inhibited ATP production in rat heart slices. 
Thus this drug theoretically provides a means of inhibiting the increased 
energy production after irradiation, which may lead to enhanced tumour cell 
ki 11. 
Mitoxantrone is an anthracenedione with structural similarities to 
doxorubicin, but without the daunosamine sugar group (149). The 
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structural formulas of mitoxantrone and doxorubicin appear below (Fig 
2.15). 
0 OH 
Fig 2.15 Structural formulas of mitoxantrone (left) and doxorubicin (right). 
The molecular formula of mitoxantrone is c22H28N4o62HC1, its name 
1,4-Dihydroxy-5,8-bis {(2-(2-hydroxyethyl)amino)-ethyl} 
amino.-9,10-anthracenedione dihydrochloride and its molecular mass is 
517.4. 
The precise mechanism of action with which mitoxantrone exerts its 
tumoricidal effects has not been fully defined (150, 151, 152, 153). 
It is most likely associated with the action of mitoxantrone on 
chromosomal elements resulting in DNA alterations, leading to 
inhibition of nucleic acid synthesis and eventual death of the ce11 
(154, 155). 
Studies by a number of investigators indicate that mitoxantrone 
inhibits RNA and DNA synthesis and intercalates into DNA (156, 157). 
Mitoxantrone interacts with both double and single-stranded nucleic 
acids by intercalating between base pairs of the DNA helix and 
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distorting that structure. However the actual structure of the 
intercalated complex has not been fully elucidated (158). 
Although the mitoxantrone molecule contains a planar aromatic 
chromophore, which might be expected to facilitate DNA intercalation, 
the presence of two extended alkyl residues on positions 1 and 4 
precludes the smooth incorporation of all parts of the molecule into 
the intercalated compound. This consideration has led to suggestions 
that binding of mitoxantrone to DNA may include both, partial 
intercalation and external binding (159, 160). Mitoxantrone binds to 
DNA whether or not the cells are in active anabolism preparing for 
cell division. It can thus kill tumour cells irrespective of their 
position in the cell cycle at the time of exposure to the drug. 
Leukemic cells cultured with mitoxantrone show a dramatic effect on 
cell progression through the cell cycle. The DNA distribution in drug 
treated cells showed a significant accumulation in the G2 phase. 
While there is a significant increase in cell volume, for mitoxantrone 
treated cells, the RNA content of these cells, which are blocked by 
the drug, increased significantly (3 fold) in the 
·treated cells (161). Traganos et al (162) also demonstrated that 
mitoxantrone treated mammalian cells in culture are blocked in the G2 
phase. This resulted in a more than 2 fold increase in RNA content. 
In leukemic cells treated with mitoxantrone, enlarged nucleoli and 
increases in levels of DNA, due to drug-induced polyploidy, are 
observed. Although cells are most sensitive to the bocking effects of 
mitoxantrone in late S phase, (manifiested as G2-M block), cell kill 
is not cell cycle phase specific. 
There are other metabolic effects of mitoxantrone related to its 
quinone functional groups (163, 164). 
These quinone agents may be enzymatically activated within the cell to 
free radicals by a microsomal enzyme system requiring NADPH as an 
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electron donor. Essentially any biological system containing NADPH 
has the potential to reduce quinone-containing compounds to free 
radical semi-quinones. The important role of free radical production, 
as well as decreasing oxygen consumption in cell metabolism after 
treatment with mitoxantrone will be more fully discussed in chapter 5 
in connection with the experimental results obtained in this thesis. 
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CHAPTER 3 
MATERIAL AND METHODS 
This chapter will describe the type and source of experimental mice and rats, 
the experimental design and the procurement of various tumour tissues. 
Following this section, experimental techniques will be detailed with 
appropriate discussion. 
3.1 Experimental Animals 
Three strains of mice were used in the investigations, namely CBA, 
BALB c and WHT. The strain of rat used was WAG/Rij. 
All experimental animals were bred in the Medical School Animal Unit, 
University of Cape Town, 7925 Observatory, South Africa. Experimental 
animals were kept in the Radiobiological Laboratories, Department of 
Radiotherapy, University of Cape Town. Mice and rats were fed with 
Epol Mouse or Rat Cubes (Atlas Feeds, 392 Main Road, Wynberg, Cape). 
Water was allowed ad libitum. 
The temperature in the animal rooms was kept at 22° + l°C. 
3.1.1 Experimental Rodents and Tumours 
3.1.2.1 CBA Mice and the CaNT Tumour 
Male CBA mice were used in the experimental work (Fig 
3.1). Their age at the beginning of any procedure was 
six weeks and their weights ranged from 18 to 24g. 
The experimental CaNT tumour was originally obtained 
from Professor R. Berry of the Middlesex Hospital 
Medical School, University of London, England, and 
maintained by serial passage ·(see 3.1.3.1). 
The volume of the tumours (as deduced from measurements 
in 3 orthogonal directions - See 3.1.2.4) used in these 
investigations was between 150 and 300mm3 • 
Fig 3.1 
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Male CBA mouse with CaNT tumour (arrow) 
3.1.2.2 BALB c Mice and the 3-Methylcholanthrene - Induced 
Transplantable Rhabdomyosarcoma. 
A transplantable rhabdomyosarcoma was induced by 
injection of 0.1 ml of a 1mg/ml solution of 
3-methy l cholanthrene in arachis oil subcutaneously into 
the right thigh region of six 6 week old male BALB c 
mice (Fig 3.2). It was found that a rhabdomyosarcoma 
developed in all mice in approximately 3 to 4 months . 
Male BALB c mice used in the studies described 
hereunder were 6 weeks old, with a weight range of 18 
to 22g, before any procedure took place. The 
rhabdomyosarcoma was maintained by serial passage in 
the upper right leg of the BALB c mice (see 3.1.3.1), 
which was also the position used in the experiments. 
The volume of the tumours (as deduced from measurements 
in 3 orthogonal directions - see 3.1 .2.4) used in the 
investigations was between 150 and 300 mm 3 • 
Fig 3.2 
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Male BALB c mouse with a transplantable rhabdomyosarcoma (arrow) 
3.1.2.3 WHT Mice and the Fib/t Tumour. 
Male WHT mice were used whose age before any procedure 
was 6 weeks. The weight range was 18 to 23g. The 
transplantable Fib/t murine fibrosarcoma was grown on 
the sternum region of the WHT mice. This tumour was 
obtained from Dr N. McNally of the Gray Laboratories of 
the Cancer Research Campaign, Mount Vernon Hospital, 
Northwood, Middlesex, England, and maintained by serial 
passage (see 3.1.3.1). 
Again, the volume of the tumour as calculated from 
measurements in 3 orthogonal directions used in the 
experiment was between 150 and 300 mm 3 (see 3.1.2.4). 
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3.1.2.4 Measurement of Volume of Experimental Mouse Tumours. 
Mouse tumours were measured in 3 orthogonal directions 
using Vernie r calipers. The following formula was used 
to calculate the volume: 
This assumed the experimental tumours to be of 
spherical shape. 
3.1.2.5 WAG/Rij Rats dnd the R1 Tumour 
Male WAG/Rij rats were used. The age of the rats was 8 
to 10 weeks and the weight ranged from 160 to 220g (Fig 
3.3). The transplantable rat rhabdomyosarcoma Rl was 
grown on the flank of these WAG/Rij rats, and 
maintained by serial passage (see 3.1.3.2). This 
tumour was obtained originally from Dr G.W. Barendsen, 
Radiobiological Laboratories, Rijswijk, The 
Netherlands. 
Fig 3.3 Male WAG/Rij rat with rhabdomyosarcoma R1 (arrow) 
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3.1.3.1 Propagation of Tumours in CBA, BALB c and WHT mice. 
Tumour-bearing mice were killed by prolonged exposure 
to ether, then tumours removed by surgical excision. 
Approximately 5 mt of McCoy's 5A medium with 
L-Glutamine and NaHC03 to adjust the pH to between 7.2 
and 7.4 was put in a 65x15mm Falcon Plastics petri 
dish, and tumours from 3 animals added. Tumour 
specimens were chopped finely in small pieces using 
sterile blades. 
After chopping the total preparation was aspirated 
through a 12x38mm size needle into a sterile syringe 
(B-D plastipak). The supernatant containing tumour 
cells was then placed into a plastic test tube (Falcon) 
and the preparation was allowed to settle for a few 
minutes. 
Subsequently 0.1 mt of the upper layer of the 
preparation was inoculated using 0.45x13mm needle by 
subcutaneous injection •. 
The CaNT and Fib/t tumour cell suspensions were 
injected subcutaneously into the sternal region of 
respectively CBA and WHT mice, and 3-methylcholanthrene 
induced rhabdomyosarcoma cells into the outside right 
upper leg of BALB c mice. 
The experimental tumours appeared 10 to 20 days after 
inoculation. 
3.1.3.2 Propagation of Tumour in WAG/Rij Rats 
Tumour-bearing rats were killed by prolonged exposure 
to ether and the tumours excised. Tumours were placed 
in medium as described in 3.1.3.1 above. Afterwards 
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the tumour specimens were chopped up with surgical 
blades and a cube of tissue of size about 2mm3 was 
inserted with forceps into a small incision in the 
posterior right lateral mid-thigh region of WAG/Rij 
rats. The experimental tumour appeared about 20 days 
after the inoculation of the tumour. 
3.1.3.3 Clamping of the CaNT tumours in CBA Mice. 
The procedure adopted to clamp the CaNT tumours grown 
on the sternum of CBA mice was to retract the tumour 
and associated skin away from the body of the 
ether-anaesthetized mouse and tie a thin string firmly 
around the skin flap between the host and tumour. This 
clamp should in principle prevent blood from flowing 
through the blood vessels into the tumour. 
The clamp was left in place for up to 2h. 
3.2.1 Tissue Culture Techniques 
3.2.1.1 Cell Line and Cell Culture Conditions 
The 816 mouse melanoma cell line is an established line 
and can be cultured in vitro using essentially the 
method outlined by Puck and Marcus (165). The cells 
were cultured in 25cm2 plastic tissue culture flasks 
(Falcon Plastics) using McCoy's medium (Gibco) 
supplemented with 10% foetal calf serum and the 
antibiotics neomycin, penicillin, and streptomycin. 
The final concentrations of the latter in the medium 
were respectively 0.5U/ml, 0.25U/ml and 0.25U/ml. 
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Cells were grown at 37°C and in a humidified atmosphere 
containing 5% co2. 
3.2.1.2 Sub-culture of B16 Cells 
Reagents 
(a) EDTA in phosphate buffered saline was made up to 10 
times the required concentration. A solution was made 
up containing NaCl, 82g; Na2HP04, 12.78g; 
NaH2Po4.2H20, 2g and EDTA disodium salt, 2g in 1.e. The 
pH was adjusted to 7.4 with concentrated NaOH solution, 
and the reagent was filter sterilized through a sterile 
0.22 ~m Millipore filter. The stock EDTA solution was 
stored frozen in 10 m.e aliquots. The stock solution 
was diluted 10 fold with sterile water before use. 
(b) Trypsin in phosphate buffered saline was also made 
up as a 10 times concentrated stock solution. The 
trypsin solution was prepared thus: NaCl, 82g; 
Na2HP04, 12.78g; NaH2Po4.2H20, 2g; EDTA disodium salt, 
1g and trypsin (Difco 1:250) 5g were dissolved in 1.e of 
water, the pH adjusted to 7.4 with concentrated NaOH, 
then filter sterilized through a sterile 0.22 Millipore 
filter. This stock solution was also stored frozen at 
-20°C in 10 m.e aliquots. The stock trypsin solution 
was diluted 10 fold with sterile water before use. 
Procedure 
Medium was poured off the cells (stock 816 cell 
cultures), then the cells were rinsed twice with 3 m.e 
0.02% EDTA in phosphate buffered saline. Cell cultures 
were then trypsin i zed by the addition of 2 m.e 0. 05~~ 
trypsin solution, which was left in contact with the 
cells for 4 to 6 min at 37°C in a co2 incubator. The 
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cells became detached from the bottom of the culture 
flasks by this procedure, then the contents of the 
flasks were transferred to plastic centrifuge tubes. 
Two ml of McCoy's growth medium conaining 10% foetal 
calf serum and antibiotics were added to each tube, 
then tubes were centrifuged at 1000 rpm for 5 min in a 
Runne bench-top centrifuge. The supernatants were 
discarded and the cell pellets resuspended in 5 ml 
growth medium; The cell concentrations were obtained 
by counting a sample of the cell suspensions in a 
haemocytometer, then the volumes containing 2x105 cells 
were pipetted into clean sterile 25 cm 2 Falcon flasks. 
Growth medium was added to result in a total volume in 
each flask of 5 ml. 
Flasks were placed in a humidified co2 incubator at 
37°C, then periodically checked with an inverted 
microscope {Wild) to monitor growth. Medium was 
changed when colour changed to yellow. Cells were 
cultured until they. became confluent, when they were 
either further sub-cultured or used in experiments. 
3.3.1 Irradiation Techniques - Ionizing Radiation 
3.3.1.1 Restraining Device for Mice. 
The CBA, WHT and BALB c mice with experimental tumours 
and which were to be subjected to irradiation were 
positioned on a jig made of Perspex {acrylic plastic). 
The mice were immobilized on the jig with rubber bands 
on the front and back legs as shown in Fig 3.4 (CBA 
mice). Mice were not anaesthetized during irradiation. 
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Fig . 3. 4 Restraining device for mice during irradiation 
3.3.1.2 Medium Voltage X-ray Unit . 
3.3.1.3 
A large proportion of the x-irradiations in this 
investigation was performed with a Philips RT100 X-ray 
unit, 100 kVp, 3.0mm Al HVL, 8mA. A source to surface 
distance (SSD) of 12 . 5cm was used with a circular field 
of diameter 2.5cm. 
Dosimetry of the 100 kVp X- ray Unit . 
The x-ray unit was calibrated with a flat (small volume 
- 0.3cm3 ) ionization chamber connected to a 
Baldwin-Farmer substandard dos ,i!neter and placed at the 
end of a circular applicator, diameter 2.5cm, SSD 10cm . 
The dose rate at this distance in the centre of the 
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field was measured to be 7.36 Gy min- 1 when the output 
of the machine was 65 Roentgens min-1, measured at 30cm 
SSD using a circular applicator, diameter 5cm. The 
output was measured weekly at 30cm SSD with the 
circular Scm diameter applicator, and changes in output 
were corrected for in the calculation of dose given to 
the experimental tumours. Tumours on the sternum were 
irradiated in such a way that half the dose was given 
from one side and half the dose from the other. This 
aided dose homogeneity. The variation in x-ray dose 
across the tumour was calculated to be not more than 
17.02% (166). All parts of the mice apart from tumour 
were shielded with 3mm thick lead. 
3.3.1.4 Irradiation of Rl Rat Tumours with 8MV X-rays 
WAG/Rij rats were immobilized using a jig as shown in 
Fig 3.5. Rats were not anaesthetized during 
x-irradiation. The rat sarcoma was irradiated with 8 
MV x-rays from a Philips SL75-20 linear accelerator, 
using a 5x5cm field. Two em thick blocks of acrylic 
plastic were positioned in front of the tumour as 
build~up material. Lead blocks 7.5cm thick shielded 
all parts of the rat apart from the tumour. 
The tumour dose given was lOGy. Calibration of the 8 
MV x-rays was with an ionization chamber positioned in 
the same position as the tumour, and connected to a 
Baldwin-Farmer dos , meter. 
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Fig 3.5 Restraining device for rats during irradiation. 
3.3.1.5 Irradiation of Experimental Mouse Tumours with 60co 
gamma rays 
Mice were restrained in acrylic plastic jigs. 
Irradiation was using a Picker model V4M/60 unit which 
emitted gamma radiations of 1.17 and 1.31 MeV. All 
parts of the mice were shielded with 7.5cm thick lead 
blocks, apart from the tumour. Blocks of acrylic 
plastic 0.5cm thick were placed in front of the tumours 
for build-up. 
Dose in February 1986 was 1.1906 Gy min-1 for this 
unit. 
3.3.1.6 Irradiation of 816 Mouse Melanoma Cells 
Cells were grown to confluence in 25 cm 2 Falcon flasks. 
Medium was changed, then the cells were irradiated 
using an Eldorado 6 60co unit (Fig 3.6). 
Fig 3.6 
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Irradiation of 816 mouse melanoma cells with 60co gamma rays. 
The distance from the spurce to the cell layers at the 
bottom of the flasks was 80cm. A sheet of acrylic 
plastic (Perspex) 0.5 em thick was placed on the upper 
surface of the flasks to provide build-up. 
The output of the 60 co unit was measured to be 0.598 
Gy/min on 6 June 1986 at a source to surface distance 
of 80.63 em using an 0.5 cm 3 ionization chamber 
connected to a substandard Baldwin-Farmer dos ~meter. 
In order to calibrate the Eldorado 6 for irradiating 
cells in the geometric set-up described above, a flat 
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ionization chamber was placed underneath and against 
the bottom surface of a Falcon flask containing the 
cells and medium . Care was taken to maintain a 
distance of 80 em from the source to the bottom of the 
Falcon fl ask . A sheet of acrylic plastic 0.5 em thick 
was placed on top of the flasks, t hen dose was measured 
by connecting the ionization chamber to a substanda rd 
Bald\'Jin-Farmer dos~ meter. 
3.3.2.1 Clonogenicity Ass ays 
Confluent cells were treated by exposure to 
x-irradiation, mitoxantrone or both. After the medium 
was poured off, ce 11 s were tryps i ni zed as .desc;ri bed in 
3.2.1.2, the ce l l concentrations obtained by counting 
in a haemocytometer, then volumes conta ining 400 cells 
were pipetted into cl ean sterile 25 cm 2 Falcon flasks. 
Growth medium was added to result in a volume of 5 m~, 
then flasks were placed i n a humidified C02 incubator. 
Colonies were stained after 11 days incubation by 
removing the medium and adding about 2 m.e gentian 
violet solution (1 % in water). The stain was left in 
contact with the cells for 12-15 minutes, removed and 
the flasks were washed thoroughly with water. Flasks 
were dried overnight and the number of colonies 
counted. The surviving fraction was calculated by 
comparison of the number of colonies in experimental 
flasks with those in untreated or control flasks, and 
response curves could then be constructed (182). 
3.4.1 
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Exposure to Magnetic Fields. 
3.4.1.1 Positioning of Mice in a Magnetic Field. 
CBA mice with experimental CaNT tumours subjected to 
exposure in magnetic fields were kept in a non-magnetic 
mouse cage and fed with Epol Mouse Cubes. Water was 
allowed ad libitum (Fig 3.7). Control mice were also 
kept in these conditions, but away from artificial 
magnetic fields. 
Fig 3.7 CBA mice with CaNT tumours exposed to magnetic fields. 
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3.4.1.2 Magnetic Resonance Imaging Unit (MRI). 
The MRI unit used was a Gyrex 5.5000 system which 
employs a superconducting magnet. It has a resistance 
of no more than 4xlo- 11 ohms which generates a field 
intensity of 0.5 Tesla. The unit can also employ a 
radiofrequency (RF) component of 20 MHz. 
The magnet dimensions are: height - 249cm; depth -
250cm; width - 215cm and its mass is 5 000 kg. 
Temperature in the MRI laboratories was regulated 
between 20°C and 22°C. Relative humidity was regulated 
at 40% to 60% (non condensing). This equipment is the 
first to be installed in South Africa and the Southern 
Hemisphere and is located in the Research Institute for 
Medical Biophysics of the South African Medical 
Research Council (MRC), Tygerberg (Fig 3.8). 
Fig 3.8 Operator's console of the MRI. 
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3.4.1.3 Measurement of the Spin-Lattice (T1) and Spin-Spin (T2) 
Relaxation Times in Proton Magnetic Resonance Imaging 
(MRI) in the CaNT.Murine Tumour 
Male CBA mice with the CaNT tumour in the sternal 
region (see 3.1.2.1) were held in a perspex jig. Two 
such jigs holding two mice each were placed into the 
head coil of the MRI system. 
A sealed perspex cube containing 1.7t of a calibration 
solution of NiC1 2 (20 mM) was also inserted into the 
head coil in order to supply sufficient electromagnetic 
wave absorption necessary for the radiofrequency 
calibration of the ~esonance signals. The ensemble in 
the head coil was located so that it would be situated 
within the volume of greatest homogeneity at the centre 
of the static magnetic field (Fig 3.9). 
A rectangular region of interest (ROI) was defined on 
the computer for each of the CaNT tumours. The 
dimensions of the ROI were such as to include each 
tumour, without extending beyond its boundaries. In 
turn this enabled one to calculate the average T1 and 
T2 values for each tumour (167). 
The Elscint Gyrex 5000 NMRI system was used for these 
measurements of T1 and T2 at 21°C and 20 MHz. 
A m~p of T1 values was construct~d from two spin-echo 
images in which the repetition tfme (TR) was varied but 
the echo time (TE) kept constant. The times used were: 
TR1 = 200ms 
TR2 = BOOms 
TE = 40ms 
TE = 40ms 
Data Collection 
and 
Processing 
System 
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Gradient Coils 
RF Coils 
~--~·--· 
- -
Patient Table 
Operator's Console 
and 
Diagnostic Station 
Fig 3.9 A schematic layout of an NMRI system. 
3.5.1 
A map of T2 values was also constructed from two 
spin-echo images in which the TR was kept constant but 
the TE varied. Times used were: 
TR = BOOms TE 1 ;: 40ms TE2 ;: 160ms 
Preparation of Tumour Tissue 
The tumours from CBA and WHT mice and WAG/Rij rats were treated 
in two different ways as detailed in 3.5.1.1 and 3.5.1.2 
immediately following their removal by surgical excision after 
the animals were anaesthetized with ether. 
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3.5.1.1 Tumour tissue preparation for Glucose-6-Phosphate 
Dehydrogenase (G-6-PDH), Isocitrate Dehydrogenase (ICDH), 
Phosphomannose Isomerase (PMI) and Tissue Sulphydryl Levels. 
Tumour tissue was weighed out and homogenised 1:5 w/v with 
ice cold homogenizing medium, which consisted of 
physiological saline (0.9% NaCl w/v) which was 0.66 mM with 
respect to EDTA. A Potter-Elvehjem homogenizer was used. 
The sample was centrifuged (Sorvall RC-58 centrifuge) for 20 
minutes at 17540g at 4°C. The clear supernatant fluid was 
removed from the centrifuge tube with a disposable Pasteur 
pipette. The homogenate was stored under ice for a maximum 
of 1 hour before any of the assays. 
3.5.1.2 Tumour tissue preparation for ATP Assay 
I' 1 
. -' 
\' ' 
Mice were anaesthetized with ~ther, and the skins and tissue 
surrounding the tumour we~e removed, as was obviously 
necrotic ·tissue. Tumour was cut away and immediately 
dropped into liquid nitrogen. Frozen tumours were quickly 
weighed, then pulverized in a mortar with frequent.additions 
of liquid nitrogen. One me perchloric acid (6% w/w) was. 
added and the tissue was ground to powder, again with 
further additions of liquid nitrogen. The liquid nitrogen 
was allowed to evaporate, the mixture liquefied and was 
homogenized in a Potter type glass homogenizer. The , ." 
homogenate was centrifuged at 17500g for 20 minutes at 4°C, 
the supernatant removed and the pH adjusted to between 
7.4-7.5 with 5M K2co3• · This was centrifuged at 17500g for 
20 minutes, and the supernatant was used for ATP 
determinations. 
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3.5.1.3 Preparation of Cells for ATP Determination 
Following irradiation or other treatments, flasks were 
replaced in the incubator at 37°C and exposed to a 
humidified atmosphere containing 5% co2 for up to 2.5h 
following irradiation. · Cells were then trypsinized as 
detailed in 3.2~1.2 and resuspended in 5 ml serum-free 
McCoy's medium. Cells were counted in a haemocytometer, 
then the volume containing 1x106 cells was placed in a 
plastic tube. One ml perchloric acid. {6% w/v) was added, 
then the sample was freeze-thawed three times by immersion 
of the closed tube into liquid nitrogen followed by warming 
at 37°C·in an incubator. 
After the last ·thawing, the preparation was centrifuged at 
17500g for 20 min. at 4°C in a Sorvall RC-58 centrifuge. 
The supernatant was removed, made up to 20 ml with.water and 
the pH adjusted to 7.5 with 5M potassium carbonate. This· 
was followed by recentrifugation at 17500g for 20 min. at 
4°C. 
ihe volume of supernatant was measured, and this was used 
for determination of cellular ATP levels using the highly 
sensitive luciferin-luciferase system {see 3.6.1.5 below). 
3.6.1 Biochemical Assay Techniques 
I 
Methods used for the assay of the following will be discussed: 
{1) Glucose-6-phosphate dehydrogenase {G-6-PDH) activity; 
{2) Isocitrate dehydrogenase {ICDH) activity; 
(3) Phosphomannose isomerase (PMI) act1vity; 
{4) Adenosine-5'-triphosphate (ATP) 1 evel s; 
(5) Tissue sulphydryl levels; 
(6) Protein determinations. 
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Each of the experimental techniques used will be presented in the 
following format: 
(a) Principles of the particular assay will be discussed. 
(b) A detailed account of materials and methods will be given. 
(c) The assay procedure will be succinctly described. 
(d) Comments on any particular assay will be made when 
necessary. 
The methods for calculation of results from the experimental data 
as well as statistical methods are given in Appendix B. 
3.6.1.1 Glucose-6-Phosphate Dehydrogenase (D-Glucose-6-phosphate-
NADP !-oxidoreductase, EC 1.1.1.49) 
Principles of Assay 
Glucose-6-phosphate dehydrogenase (G6P-DH) was first 
isolated from erythrocytes and from fermenting yeast by 
Warburg et al. The molecular weight of the enzyme is 
128000. G6P-DH was determined as described by Lohr and 
Waller (168). Blood cells, adipose tissue and lactating 
mammary gland are especially rich sources of the enzyme. 
Less occurs in liver, pancreas, kfdney, lung, brain and 
gastric mucosa, while only traces are found in skeletal and 
heart muscle and virtually none in serum. Some human and 
animal tumours contain high activity of the enzyme. The 
first reaction of the phosphogluconate pathway is the 
enzymatic dehydrogenation of glucose-6-phosphate by glucose 
6-phosphate dehydrogenase, also known as Zwischen ferment, 
to form 6-phosphogluconate. Under the conditions of the 
assay, the reaction involved is shown in Equation 3.1. 
+ G6P;DH 
Glucose-6-phosphate + NADP 6-Phosphogluconate + + . 
NADPH + H+ (Equation 3.1) 
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Dehydrogenation of glucose 6-phosphate by G6P-DH forms 
6-phosphogluconate. This enzyme, which is not present in 
mitochondria is specific for NADP as electron acceptor. It 
carries out dehydrogenation of carbon atom 1 of the pyranose 
form of glucose 6-phosphate to yield the corresponding 
6-phosphoglucose-o-lactone. 
Materials and Methods 
The sample of the experimental mouse tumours was freshly 
prepared as detailed in 3.1.6.1 and kept under ice, ready to 
utilize for the enzymatic assay. 
The different reagents used to prepare the solutions had the 
following concentrations: 
(a) Triethanolamine 50 mM~ buffered to pH 7.5 with 1 N NaOH 
(b) Nicotinamide-adenine dinucleotide phosphate (8-NADP): 
30 mM. 
(c) Glucose-6-phosphate (G-6-P): 40 mM. 
The rate of formation of NADPH was used as a measure of the 
enzyme activity and followed by means of the increase in 
extinction at 340 nm using a Pye Unicam 5P8-400 UV/V15 
double beam spectrophotometer. 
Assay Procedure 
The total volume of 1.2 ml was contained in 1.5 mt quartz 
glass cuvettes. For the measurement, the reference cuvette 
contained: Triethanolamine buffer: 57.12 ~mol (pH 7.5), 
0.010 mt tumour sample. 
The sample cuvette contained triethanolamine 52.20 ~mol (pH 
7~5), nicotinamide-adenine dinucleotide phosphate (s-NADP): 
10 nmol, glucose-6-phosphate: 13.4 nmol, 
0.010 mt tumour sample. 
Absorbance change at 340 nm was monitored at 25°C for 3 min. 
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Corrments 
The enzymatic reaction kinetics were linear using between 
0.005 and 0.025 mt of tissue homogenate from the 
experimental mouse tumours. 
3.6.1.2 Isocitrate Dehydrogenase (Threo-Ds-isocitrate: NADP+ 
oxidoreductase-decarboxylating-EC 1.1.1.42). 
Principles of assay 
Isocitrate dehydrogenase (ICDH) is widely distributed in 
nature. The enzymeis a component of the Krebs 
tricarboxylic acid cycle, and has been studied in bacteria, 
protozoa, fungi, yeasts, higher plants, insects and mammals 
including man. 
ICDH activity was determined as described by Bernt and 
Bergmeyer (169). In mammalian tissues there are two 
NADP-specific ICDH isoenzymes located in the mitochondria 
and cytoplasm respectively (170)~· The isoenzymes of these 
two cell compartments are under independent genetic control. 
In mammalian cells, the heart and skeletal muscle contain 
predominantly the mitochondrial NADP-specific isoenzyme, 
whereas the liver contains mainly the cytoplasmic 
NADP-specific isoenzyme (171). Mammalian NADP-specific ICDH 
enzymes generally have a molecular weight less than 96000 
and consist of a single polypeptide chain, or have a dimeric 
structure. The reaction that involves ICDH is shown in 
Equation 3.2. 
. + IrDH + Threo-Ds.-Isoc1 trate+NADP +2+ 2-oxogl utarate+NADPH+C02+H Mn (Equation 3.2) 
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The NADP-specific isocitrate dehydrogenase requires Mn2+ for 
its activity. The reaction proceeds with a large decrease 
in Gibbs free energy because of the simultaneous loss of the 
beta-carboxyl group as C02 in the highly exergonic reaction. 
Materials and Methods 
The sample of the experimental tumours was freshly prepared 
as detailed in 5.1.6.1 and kept under ice for not more than 
one hour before startirig the assay. 
The different reagents used to prepare the solutions had the 
following concentrations: 
(a) Triethanolamine buffer 38.6 mM (pH 7.3). 
(b) DL isocitrate 1. 70 mM 
(c) NaCl 19.32 mM 
(d) a-NADP 0.12 mM 
(e) MnS04.H20 1.56 mM 
The rate of formation of NADPH was used to measure the 
enzyme activity. A Pye Unicam 5P8-400 UV/V15 
spectrophotometer with a thermostatted cuvette holder (25°C) 
was used to measure the increase in absorbance at 340 nm. 
Assay Procedure 
The total assay volume of 1.2 mt was contained in 1.5 mt 
quartz cuvettes for the measurement of ICDH activity, the 
reference (control) cuvette contained triethanolamine buffer 
95.6 ~mol {pH 7.5), DL-isocitrate 4.42 ~mol, NaCl 50.19 ~mol 
and 0.005 mt tumour sample. 
The sample cuvette contained triethanolamine 92.4 ~mol {pH 
7.5), DL-isocitrate 4.27 ~mol, NaCl 78.51 ~mol, 
nicotinamide-adenine dinucleotide phosphate (a-NADP) 12.8 
nmol, Mnso4 ~.15 ~mol and 0.005 mt tumour sample. 
- 74 -
Absorbance changes were measured in isothermic conditions, 
at 25°C for 3 minutes. 
Comment 
Bernt et al (169) observed that ICDH lost 30% of activity 
after 3 days at 4°C. 
In this study the activity of the ICDH, was always measured 
within 1 hour of preparation of the sample. 
3.6.1.3 Phosphomannose Isomerase (D Mannose-6-phosphate 
Ketal-isomerase, EC 5.3.1.8) 
Principles of assay Ill 1947 Gottschalk (172) suggested that 
the conversion of glucose-6-phosphate and 
mannose-6-phosphate to the common intermediate, 
fructose-6-phosphate, is catalyzed by two separate and 
specific enzymes which he designated Isomerase I and II. 
+ + Glucopyranose-6-P + Fructofuranose-6-P + Mannopyranose-6-P 
Isomerase I Isomerase II 
Isomerase I had been identified in 1933 by K Lohmann (142) 
as phosphoglucose isomerase. It was not until 1950 that the 
existence of Isomerase II, Phosphomannose isomerase (PMI), 
as a separate enzyme was positively demonstrated by Slein 
(173). PMI activity was determined in this research work, 
using the method described by Gawhn (174). 
The reactions that involve PMI are shown in the following 
equations (3.3, 3.4 and 3.5). 
Mannose-6-P PMI Fructose-6-P (Equation 3.3) 
+ 
Fructose-6-P PGI + 
+ Glucose-6-P + NADP 
Glucose-6-P {Equation 3.4) 
G6P-DH 
+ 
+ Gluconate-6-P + NADPH + H . {Equation 3.5) 
] 
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The assay.for PMI (Equation 3.3) is performed indirectly in 
the following way. The two enzymes PGI and G6P-DH are added 
in excess to Mannose-6-P and the final reaction (Equation 
3.5) is observed using a spectrophotometer to measure the 
absorbance of NADPH at 340nm. In this way the activity of 
PMI is determined, since its action is the rate limiting 
step in Equations 3.3, 3.4, 3.5. 
Materials and Methods 
The sample to measure phosphomannose isomerase (PMI) 
activity in the experimental tumours was freshly prepared as 1-
detail~d in 3.5.1.1 and stored under ice. The various 
reagents used in the as~ay had the following concentrations: 
(a) Triethanolamine buffer: 50 mM (pH 7.6) 
(b) Mannose-6-P, K ·salt: 3;2 mM 
(c) 8-NADP: 11 niM . . ·. 
(d) Phosphoglucose isomerase (PGI) 560 U/mg 
(e) Glucose-6-Phosphate dehydroge'nase (G6P-DH) 400 U/mg 
A Pye-Unicam SPB-400 UV/V15 dual beam spectrophotometer with 
a· thennostatted ·cuvette holder (25°C) was used to measure 
the absorbance.change at 340 nm. 
Assay Procedure 
The total volume of 1.2 mt was contained in 1.5 me quartz 
glass cuvettes. The reference cuvette contained: · 
triethanolamine buffer 96.24 ~mol (pH 7.6) 
mannose-6-phosphate, K saJt, 32 nmol and 0.010 me tumour 
sample. 
The sample cuvette .contained: 
triethanolamine b~ffer 91.12 ~mol (pH 7.6), 
mannose-6-phosphate, K salt 32 nmol, NADP, Na salt 20 nmol, 
PGI. 16 Units,.G6P-DH 195 units and 0.010 mt tumour sample. 
- 76 -
Absorbance changes were monitored at pH 7.6 and 25°C for 3 
minutes. 
3.6.1.4 Adenosine-5'-Triphosphate 
Principles of assay 
Of all the naturally occurring phosphates, 
adenosine-5'-triphosphate, is the most widely distributed. 
This energy-rich nucleotide serves as an 11 energy pool 11 to 
meet the energy requirements of cellular metabolism. 
The enzymatic determination of adenosine-5'-triphosphate 
(ATP) by a spectrophotometric method as developed by 
Lamprecht and Trautschold (175) and used in this present 
work makes use of the fo 11 owing reactions: 
Hexokinase (HK) (ATP : D-hexose-6-phosphotransferase, EC 
2.7.1.1) phosphorylates glucose with ATP in the presence of 
Mg2+ to glucose-6-phosphate (G-6-P). G6P-DH 
(D-Glucose-6-phosphate NADP1-oxidoreductase, EC 1.1.1.49) 
catalyses the dehydrogenation of G-6-P with NADP to give 
6-phosphoglucono-~-lactone. The reaction scheme is given in 
Equation 3.6. 
ATP + Glucose 
G-6-P + NADP+ 
HK G-6-P + ADP 
G-6-PDH. 6-Phosphoglucono~5-lactone + 
NADPH + H+ (Equation 3.6). 
+ 
For each mole of ATP present, 1 mole of NADPH is formed, and 
can be determined spectrophotometrically at 340 nm. 
Materials and Methods 
The tissue sample of the experimental mouse tumours was 
freshly prepared as detailed in 3.5.1.2 and kept in ice. 
The reagents required for the assay were: 
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(a) Triethanolamine buffer: 50 mM (pH 7.4) 
(b) Nicotinamide-adenine dinucleotide phosphate 
(a-NADP): 10 mM. 
(c) Magnesium chloride (MgC1 2): 0.1 M 
(d) Glucose 6-phosphate dehydrogenase (G-6-PDH): 400 
U/mg 
(e) Hexokinase (HK): 480 U/mg 
(f) Glucose: 0.5 M. 
The absorbance changes at 340 nm were monitored with a 
Pye-Unicam SPS-400 UV/V15 dual beam spectrophotometer. 
Assay Procedure 
Spectrophotometer sample cuvettes contained triethanolamine 
32 ~mol, NADP 1~32 nmol, MgC1 2 533 nmol and 0.1 to 0.12 ml 
tumour sample containing ATP and water in a total volume of 
1.075 mt at pH 7.4. 
Initial absorbance readings were made at 340 nm against a 
reference cuvette containing all reagents listed for the 
sample cuvette, with the exception of NADP. 
Glucose-6-phosphate dehydrogenase suspension 14.5 units was 
added to both sample and reference cuvettes, the absorbance 
at 340 nm was monitored until a constant reading was 
obtained, then 6 ~mol glucose contained in a volume of 0.12 
mt was added to both cuvettes. An absorption reading at 340 
nm was made, then 6 units of hexokinase preparation were 
added. The absorbance change at 340 nm was monitored for 20 
minutes, and a final reading made. 
Comment 
It was essential that tissue samples were very quickly 
frozen to preclude further metabolism of ATP. It is known 
that the metabolite concentration in a tissue depends on the 
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speed with which the tumour was removed and on the 
manipulations during the sacrifice of the animal. 
A sample of ATP deteriorates, because it is hydrolysed when 
standing in solution. Storage at 0°C, freezing or 
lyophilization generally leads to a decrease in the ATP 
values. For this reason in this investigation, the ATP 
levels in tumour samples were determined immediately after 
sample preparation. 
3.6.1.5 Determination of ATP using Luciferin-Luciferase Assay 
Principles of Assay 
A highly sensitive method for the determination of ATP has 
been developed using luciferase from the American firefly, 
Photinus pyralis. This enzyme catalyses a chain of 
reactions, where firstly luciferin is activated by 
adenylation followed by oxidation with atmospheric oxygen. 
On decarboxylation, oxyluciferin is formed in the excited 
singlet state, which returns to the ground state by emission 
of a photon. This reaction has a very high quantal yield, 
of the order of 90%, so that the system is eminently 
suitable for making highly sensitive measurements of ATP 
concentrations (176). 
Materials and Methods 
Reagents required for the assay were: 
(a) Luciferin-luciferase (Sigma Chemical Company, St Louis, 
U S A) dissolved in deionized water to result in a 
concentration of Bmg/mt. This solution was wrapped in 
aluminium foil and stored in the dark at 4°C for 
between 5 and 24h before use. 
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(b) Tris-acetate buffer was prepared by adjustment of the 
pH of tris-(hydroxymethyl) aminomethane solution to 
7.75 with glacial acetic acid. The final concentration 
of the buffer was 0.25M. 
(c) A stock solution of ATP (0.5mM) was prepared by 
dissolving 27.56mg ATP (from equinine muscle, Sigma 
Chemical Company, St Louis, U SA) in 100 mt deionized 
water. Stock solution was diluted 1:1000 just prior to 
the start of the assay. 
Bioluminescence was measured using a Beckman Liquid 
Scintillation Counter, Model LS 1801, which wa~ programmed 
to make use of the single photon monitor. Samples were 
counted for 0.1 minutes. Individual samples were counted 
immediately after preparation, and it was foun~ that good 
reproducibility was achieved if sample preparation time and 
exposure to light were limited to the shortest possible 
periods. 
Assay Procedure 
Luciferin-luciferase solution 0.01 mt was added to 
tris-acetate buffer and from 0.01 to 0.02 mt ATP preparation 
contained in a plastic scintillation counting vial. The 
final assay volume was 0.5 mt. The sample was gently shaken 
to ensure good mixing of the reagents, then taken 
immediately to the scintillation counter and counted. 
With each set of ATP determinations, a calibrat.ion curve was 
prepared. It was found convenient to add 0.003, 0.005, 
0.0075, 0.010 and 0.020 mt of the 1:1000 d~lution of the 
stock ATP solution (corresponding to 1.5 x 10-13 , 2.5 x 
10-13 , 3.75 x 10-13 , 5 x 10-13 and 1 x 10-12 moles ATP) to 
tris-acetate buffer in a test tube to result in a volume of 
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0.49 mt. Luciferin-luciferase solution (0.01 mt) was then 
added before samples were counted. The counts obtained were 
plotted against ATP content on a log-log scale, and the line 
of best fit was obtained by regression analysis. The 
concentration of ATP in the "unknown" samples could then be 
ascertained from the calibration plot. The ATP content was 
then expressed as moles ATP per cell. 
It should be noted that ATP in each sample was assayed in 
duplicate at two different concentrations, namely using 0.01 
mt and 0.02 mt of sample in the manner described above. 
Results at these two concentrations were found to be 
consistent within experimental error, (showing no variation 
in the assay of ATP content of the sample). The mean ATP 
< 
content of each. sample was calculated from the mean of the 
four separate determinations. 
3.6.1.6 Tissue Sulphydryl Levels 
Principles of Assay 
The most ubiquitous and important thiol present 1n tissues 
accepted to be glutathione (y~glutamylcysteinylglycine). 
Its apparent involvement in a multitude of biological 
functions (177) have generated a continual interest in 
methods of analysis of this cellular component, ever since 
its discovery and isolation nearly 60 years ago. Although 
the tripeptide can exist in both a reduced (sulphydryl) and 
an oxidized (disulfide) form it is maintained in vivo 
predominantly in the former state through the action of the 
equally ubiquitous enzyme glutathione reductase (Equation 
3. 7). 
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GSSG + NADPH + H+ Glutathione 
-+ 
reductase 
2G-SH + NADP+ . 
(Equation 3.7) 
(Equation 3.8) 
Tissue sulphydryl levels can be very conveniently determined 
using the reaction with 5,5 1 -dithiobis-(2 nitro) benzoic 
acid) (Ellmans reagent) (Equation 3.8). 
The chromophore product resulting from the reaction can be 
determined spectrophotometrically by measurement of 
absorbance at 412 nm. Thiols were assayed using a modified 
version of the method described by Deakin (178) with 
5,5 1 -dithiobis(2-nitro)benzoic acid (DTNB). 
Materials and Methods 
The tissue samples of the experimental rat tumours 
(rhabdomyosarcoma R1) and mouse tumours (CaNT) were freshly 
prepared as detailed in 3.5.1.1 and stored in ice for not 
longer than one hour before starting the assay procedure. 
The reagents usedin the assay were: 
(a) Sodium phosphate buffer 0.08M, pH 8.0. 
(b) Ethylenediaminetetra-acetate disodium salt 
(EDTA-Na2H2) 1.32 mM. 
(c) 5,5 1 -dithiobis 2-nitrobenzoic acid (DTNB) 0.1 M. 
(d) Reduced glutathione (GSH) Q.4 mM. 
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The absorbance of the chromophore resulting from the 
reaction of glutathione with DTNB was measured in a Pye 
Unicam SP8-400 UV/V15 dual beam spectrophotometer at 412 nm. 
Assay Procedure 
Spectrophotometer sample cuvettes contained sodium phosphate 
buffer 232 ~mol (pH 8.0) 0.010 to 0.1 mt sample containing 
GSH, 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) 10 ~mol and 
water to a total volume of 3 mt. The contents of the 
reference cuvette was the same except that the GSH -
containing sample was replaced by water. 
After allowing 15 minutes for the reaction between GSH and 
DTNB, the absorbance of t~e sample cuvette was measured 
against the reference cuvette at 412 nm at 25°C. 
Concentrations of all thiols in tissue homogenates were 
determined by comparison against a standard curve. 
This latter was prepared as in· the above assay, but 0.02 
to 1.0 ~mol GSH was substituted for tissue homogenate. 
3.6.1.7 Glutathione 
Principles of Assay 
Glutathione in its oxidised or reduced state can be very 
specifically determined by the method of Tietze (179). This 
method allows the analysis of nanogram quantities of 
glutathione and is based on the catalytic action of GSH or 
GSSG in the reduction of Ellman reagent (DTNB) by a mixture 
of NADPH and yeast glutathione reductase. The catalytic 
action of glutathione in this system resides in the 
continual enzymic regeneration of GSH, present initially or 
formed enzymatically from GSSG, following its interaction 
with the sulfhydryl reagent. 
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Materials and Methods 
The tumour samples of the CaNT tumours were homogenized as 
indicated in 3.5.1.1. A volume of 5% TCA equal to that of 
the homogenizing medium was added, and following further 
homogenization the preparation was centrifuged at 17540g for 
20 minutes at 4°C. The supernatant was used in the 
determination of glutathione levels. 
The reagents used in the assay were: 
(a) Sodium phosphate-EDTA buffer 0.1 M, pH 7.5. 
(b) Glutathione reductase, 150 U/mg. 
(c) 5'5'-dithiobis-{2-nitrobenzoic acid) (DTNB), 0.1 M. 
(d) Reduced glutathione (GSH), 0.033 mM. 
(e) Reduced nicotinamide-adenine dinucleotide phosphate 
(NADPH), 11 mM. 
Assay Procedure 
For the standard glutathione assay system, quantities of the 
compounds required are shown in Table 3.1. Components were 
dissolved in phosphate-EDTA buffer, pH 7.5 and were added in 
the amounts and in the order indicated in this table. Final 
volumes were 1.0 mt. The rate of reaction at 25°C was 
expressed as the change in absorbancy per minute at 412 nm. 
TABLE 3.1: 
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Protocol for standard glutathione assay 
Test cuvette Amount Blank cuvette 
DTNB 600 nmol DTNB 
Deproteinized sample 
Glutathione reductase 
NADPH 
1-100 ng GSH 
10 ~9 Glutathione reductase 
200 .nmo 1 NADPH 
Glutathione levels ·in the tumour homogenates were determined 
by comparison against a standard curve prepared when tissue 
sample in the standard assay was replaced by 10 to 100 ng 
reduced glutathione. Ten microliters of supernat~nt was 
diluted in 1 ml of sodium phosphate-EDTA buffer 0.1 M, pH 
7.5 and volumes between 10 and SO ~l were used in the assay. 
3.6.1.8 Protein Determination 
These were made by the method of Lowry et al (180) using 
bovine serum albumin, fraction V as a standard. All protein 
determinations were made so that the amounts measured ranged 
from 0.05 mg to 0.25 mg, thus falling within the linear· 
range of concentration as measured spectrophotometrically at 
750 nm. 
3.7.1 Electron Microscopy 
Results from electron microscopy formed part of this project. 
This work was performed in the Research Institute for Medical 
Biophysics, Medical Research Council, and methods used in these 
studies will be described briefly. 
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3.7.1.1 Electron MicroscopY Techniques 
Tumour tissue was fixed in 2.5% glutaraldehyde in 0.1 M 
cacodylate buffer, pH 7.4, rinsed in buffer and post-fixed 
in 1% osmium tetroxide. Tissue was dehydrated in ethanol 
and embedded in EBL (Spurr•s) low viscosity resin. Sections 
were cut on a Reichert Om U3 microtome using glass knives 
and stained with uranyl acetate added to lead citrate. 
Sections were viewed with a Philips 420 transmission 
electron microscope at an accelerating voltage of 60-80 kV. 
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CHAPTER 4 
RESULTS 
4.1 Some Biological Effects of Ionizing Radiation 
4.1.1 ATP levels 
ATP levels were investigated in the following mouse tumours: 
1. CaNT murine tumour in CBA mice. 
2. Fib/t murine fibrosarcoma in WHT mice. 
3. Rhabdomyosarcoma tumour in Balb C mice. 
The ATP content of tumours was determined: 
(a) under normoxic conditions. 
(b) after clamping the tumours (hypoxic conditions). 
(c) under normoxic conditions following ionizing radiation. 
(d) after clamping the tumours following ionizing radiation.· 
(e) following treatment with mitoxantrone (an anthraquinone 
drug). 
(f) Under treatment with mitoxantrone and x-rays. 
4.1.2.1 ATP content in CaNT, Fib/t and R~abdomyosarcoma tumours in 
normoxic conditions 
ATP content and changes of Gibbs free energy of formation 
(~GATP) were measured under normoxic conditions at 25°C. 
The results are presented in Table 4.1. 
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TABLE 4.1: ATP concentration in nonmoxic tumours and levels of Gibbs free 
energl of formation 
Number of Concentration 
t.G (J/mg)x1o-3 Tumour Type determinations (nmol/mg) ATP 
CaNT 68 3.42 + 0.47. 125 
Rhabdomyosarcoma 13 2.78 + 0.34 102 
Fib/t 17 2.64 + 0.39 97 
- ' 
Entries represent mean ~ SEM. 
4.1.3.1 ATP content after clamping CaNT tumours {hypoxic condition} 
Adenosine-5'-triphosphate concentration in the CaNT tumour 
in CBA mice was measured at 15 minutes and 2 hours after 
clamping the tumours. 
A tumour ATP concentration decrease below the control value 
was observed 15 minutes and 2 hours after clamping. The 
measured concentrations were 0.78 times and 0.75 times 
respectively that of the controls (P < 0.001). 
The depletion of ATP concentration is shown in Fig 4.1. 
-The Gibbs Free energy change in tumour ATP after clamping is 
presented in Table 4.2. 
TABLE 4.2: Gibbs Free energy changes in tumour ATP after clamping CaNT tumours 
Experimental Conditions 
Unclamped (normoxic control) 
Clamped (hypoxic condition) 
Clamped (hypoxic condition) 
Time of tumour clamping 
15 minutes 
2 hours 
The value of t.GATP were calculated at pH 7.4 and 25°C. 
t.G (J/mg)x10-3 
ATP 
125 
101 
98 
' 
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4.1.4.1 Tumour ATP content in normoxia following ionizing radiation 
Adenosine-5•-triphosphate levels in CaNT, Fib/t and 
Rhadomyosarcoma tumours in normoxic conditions were measured 
after x-ray irradiation {100 KVp). 
CaNT tumours were irradiated with the following doses: 
5 Gy, 10 Gy, 15 Gy, 30 Gy, 100 Gy and 200 Gy. 
Fib/t murine fibrosarcoma and Rhabdomyosarcoma were 
x-irradiated with 10 Gy. 
4.1.4.2 Levels of ATP in CaNT tumour 
{a) Effects of x-rays {5 Gy) 
Adenosine-5•-triphosphate concentrations in CaNT murine 
tumours in normoxic conditions have been determined at 
various times after an x-ray irradiation of dose 5 Gy 
was given. An increase in tumour ATP content was noted 
one hour after irradiation. A considerable 
augmentation was observed 4 hours after giving the 
x-rays, which was 1.70 times that of controls~ The·ATP 
concentration returned to the control levels 13 hours 
after x-irradiation. This is represented in the Fig 
4.2. 
The Gibbs free energy change {llGATP) of 213 x10-3J/mg 
in tumour ATP content 4 hours after x-irradiation was 
increased by 1.70 times compared with the control 
value. 
{b) Effects of x-rays {10 Gy) 
ATP levels in the CaNT-tumour in CBA mice at different 
times after x-irradiation using 10 Gy were measured and 
are shown in Fig 4.3. 
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Fig 4.1 ATP levels after clamping CaNT tumours. 
Each point represents the mean of not less than 4 values and SEM is 
indicated by the vertical bars. 
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An increase in tumour ATP content was first noted 45 
minutes after irradiation. The maximum increase was 
observed 2.5 hours after receiving the x-rays. This 
was 3.76 times that of the control, then a decrease to 
1.31 times that of the controls was observed up to 13 
hours after irradiation. This is represented in Fig 
4.3. The Gibbs free energy change in tumour ATP yield 
2.5 hours after the x-ray dose, when ATP levels were 
maximal, was 473 x 10~3 J/mg. 
(c) Effects x-rays (15 Gy). 
The variatioh-Qf ATP concentration in the CaNT tumour 
in CBA mice was measured at different times, after an 
x-ray irradiation of 15 Gy was given. 
The value of the ATP content after 45 minutes increased 
by 1.39 times that of control level. It continued to 
increase up to a maximum value of 2.09 times that of 
control at 2.5 hours after irradiation. Then ATP 
levels decreased almost to the control level 13 hours 
after irradiation. This result is shown in the Fig 
4.4. 
The Gibbs free energy changes in tumour ATP synthesis, 
2.5 hours after the x-ray, dose of 15 Gy has its 
maximum value of 263 x 10-3 J/mg. 
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Fig 4.2, ATP levels in the CaNT tumours at various times after receiving an 
x-ray dose of 5 Gy. 
Each point represents the mean of not less than 3 values and SEM is 
indicated by the vertical bars. 
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(d) Effects of x-rays (30; 100 and 200 Gy). 
The variation of ATP concentration in the CaNT tumours 
was measured after the above x-ray doses, 2.5 hours 
after x-irradiation. 
The values of ATP content after the doses of 30 Gy, 100 
Gy and 200 Gy increased by 1.69 times, 1.17 times and 
1.05 times respectively compared with the controls. 
The Gibbs Free energy changes in tumour ATP content 2.5 
hours after x-irradiation doses of 5 Gy, 10 Gy, 15 Gy, 
30 Gy, 100 Gy and 200 Gy are presented in the Table 
4.3. 
Gibbs Free energy changes in tumour ATP after x-irradiation 
* 
Dose (Gy) 
5 
10 
15 
30 
100 
200 
I ) -3* ~GATP'J/mg x 10 
187 
473 
263 
210 
146 
131 
The values of ~GATP were calculated at pH 7.4 and 
25°C. 
The variation of ATP content in CaNT tumours 2.5 hours 
after doses of 5 Gy, 10 Gy, 15 Gy, 30 Gy, 100 Gy and 
200 Gy x-rays is shown in the Fig 4.5. 
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Fig 4.4 ATP levels in the CaNT tumours at various times after receiving an 
x-ray dose of 15 Gy. 
Each point represents the n~an of not less than 3 values. SEM is 
indicated by the vertical bars. 
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4.1.4.3 Levels of ATP in Fib/t and Rhabdomyosarcoma tumours 
after x-irradiation (10 Gy). 
The levels of ATP were measured, 2.5 hours after 
x-irradiation. 
An increase in ATP Levels to 1.48 times and 1.43 times 
that of controls (P < 0.025) respectively in 
Rhabdomyosarcoma and 'Fi b/t was noted. Therefore the 
6GATP yield at 25°C was 186 x 10-3 J/mg and 179 x 10-3 
J/mg respectively. 
4.1.4.4 ATP levels after clamping CaNT tumours following 
x-irradiation. 
Measurements were made after clamping the tumour by 
using a string tourniquet for 15 minutes, followed by a 
radiation dose of 10 Gy and maintaining the tourniquet 
for a further 2.5 hours. Then ATP levels were 
determined in 12 CaNT mice tumours. The decrease of 
ATP content to 0.86 times (P < 0.005) that of controls 
was observed. Consequently the 6GATP yield at 25°C was 
107 x 10-3 J/mg. 
4.1.5.1 ATP content in CaNT tumours after treatment with 
mitoxantrone 
ATP intracellular concentration was reduced by 0.89 
times, compared to controls (P < 0.05), after both 
intraperitoneal injection of 200 ~1 of mitoxantrone, 
and a local administration of 45 ~1 inoculated directly 
into the tumour of the CBA mice. 
ATP content was measured 1 hour after treatment with 
this anthraquinone drug. 
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. 4.1.5.2 ATP levels after treatment with mitoxantrone and 
x-rays 
ATP levels were measured after the following 
procedures: 
1) Treatment with 200 Ill of mitoxantrone by 
intraperitoneal administration plus local 
mitoxantrone injection of 35 Ill into the CaNT 
tumour; 
2) After 1 hour the tumours received 10 Gy of 100 kVp 
x-rays. 
3) After a further period of 2.5 hours the ATP 
determination was made. 
The ATP yield was increased (by 1.37 times, P < 0.05) 
compared to control values. This is represented in Fig 
4.6. 
4.1.6.1 Levels of ATP in CaNT tumours after different qualities 
of ionizing radiation. 
The levels of ATP in the transplantable CaNT murine 
tumours were measured 2.5 hours after receiving 10 Gy 
of different photon energy: 100 KVp x-rays, 250 KVp 
x-rays, 60-Co y-rays (1.17/1.33 MeV) and 8 MeV x-rays. 
The resulting measured ATP concentrations with respect 
to ur.irradiated controls were 3.78 times with 100 KVp,. 
1.56 times greater with 250 KVp and 1.23 times greater 
with 1.17/1.33 MeV (P < 0.05). With 8 MeV radiation, 
the tumour ATP concentration remained unchanged to 
within the experimental uncertainty. 
These results are shown in the Fig 4.7. 
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ATP content after treatment with raitoxantrone and x-rays. 
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Fig 4.7 Levels of ATP in CaNT tumours after different photon energies. 
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The Gibbs Free energy change in tumour ATP in normoxic 
conditions with different photon energy is presented in 
Table 4.4. 
Gibbs Free energy changes in tumour ATP with different 
photon energy 
Photon energy ~GATP (J/mg) X 10-3 
100 KVp 473 
250 KVp 195 
1. 17 I 1. 31 MeV 151 
8 MeV 125 
4.1.7.1 Levels of ATP in 816 mouse melanoma cells following 
60co-gamma rays 
The levels of ATP in the 816 mouse melanoma cell line 
~ 
were measured 3 hours following 2, 4, 6, 8 and 10 Gy of 
gamma radiation from a 60co source. Maximal ATP level 
increases occurred with the 6 Gy dose (2.3 times that 
of unirradiated controls which is (6.05 ~ 0.71) x 1o- 16 
moles/cell, P < 0.05). The result is presented in 
Fig 4.8. 
4.1.7.2 ATP content in 816 mouse melanoma cells after treatment 
with mitoxantrone 
ATP concentrations were determined 3 hours after adding 
5.6 ~g/ml of mitoxantrone to the incubation medium of 
816 mouse melanoma cells. ·Intracellular ATP content 
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was reduced by 0.84 times (P < 0.025), compared to. 
control values. This is represented in Fig 4.9. 
4.1. 7.3 ATP concentration after treatment with mitoxantrone 
and 60co gamma rays 
Mitoxantrone (5.6 ~g/mt final concentration in the 
medium) was added to 816 cells immediately before they 
received 2, 4, 6, 8 and 10 Gy of gamma radiation. 
Cellular ATP levels were determined after a further 3 
hour incubation period. 
There was significant difference (P < 0.05) in the ATP 
levels of the irradiated cells compared to the 
untreated controls. These results are shown in Fig 
4.10. 
4.1.7.4 Effect of exposure of 816 mouse melanoma cells to 
varying concentrations of mitoxantrone 
In order to construct radiation dose response curves, 
when cells were exposed to both mitoxantrone and 
radiation, it was considered expedient to investigate 
firstly the effect that varying concentrations of 
mitoxantrone have on the survival levels of the 816 
cells, as determined by cell clonogenicity. 
Cells were exposed to mitoxantrone contained in the 
medium, at concentrations varying from 10-4 to 
0.5~g/m.e. Exposure to the drug was for 4 hours, 
followed by washing out of the mitoxantrone and pla~ing 
out of the cells. Flasks containing the cells and 
growth medium were placed in the incubator and after 11 
days colonies were stained and counted. 
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As can be seen from Fig 4.10(a) a threshold dose of 
approximately 5x10-3J..lg/rnt was apparent', after which 
there was an approximately linear relationship with 
surviving fraction, on a log-log plot. 
Because of the extremely low surviving fractions 
expected at concentrations of mitoxantrone used in 
prior experiments (Section 4.1.7.3), it was considered 
desirable to use a mitoxantrone concentration of 
0.5J..lg/mt in the remainder of the dose response studies. 
It was also considered useful to determine ATP levels 
following exposure to a mitoxantrone concentration of 
0.5J..lg/mt for 4 hours. These levels were compared with 
those of unirradiated cells and also cells receiving a 
dose of 6 Gy of 60co-gamma rays (Table 4.5). 
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ATP concentration ir1 816 mouse melanoma cells after treatment with 
mitoxantrone. 
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ATP levels in B16 melanoma cells after treatment with 60co-gamma 
rays and mitoxantrone. 
Treatment + f moles ATP/cell (- SEM) 
Controls 
60co-gamma rays (6 Gy) 
Mitoxantrone {0.5 ~g/mt) 
60co-gamma rays (6 Gy) plus 
mitoxantrone {0.5 ~g/mt) 
1.67 + 0.19 
2.47 + 0.30 
2.59 + 0.23 
2.70 + 0.27 
As can be seen from Table 4.5, a somewhat unexpected finding was 
that mitoxantrone at a concentration of 0.5~g/mt did not cause a 
significant decrease in ATP levels, compared with the case of 
mitoxantrone at a concentration of 5.6~g/ffit (see Section 
4.1.7.2). This might be because mitoxantrone at the lower dose 
{0.5~g/mt) might cause repairable damage to cells, which can lead 
to increased energy demand, i.e. increased ATP. In this 
situation, it may therefore be expected that no decrement of ATP 
following mitoxantrone and gamma-irradiation applied together may 
occur, as was described above. 
4.1.7.5 Radiation response curves after treatment with 
mitoxantrone 
Radiation dose response curves were constructed in the 
presence and absence of mitoxantrone (0.5 ~g/mt). 
Cells were exposed to the drug (a) for 10 minutes 
before and for 4 hours after irradiation, (b) for 4 
hours after irradiation, the drug added immediately 
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after irradiation. After the 4 hour period, cells were 
washed and plated out •. Because of the very l'ow plating· 
efficiency observed at a dose of 0.5~g/mt mitoxantrone, 
it was necessary to plate out 104 cells per flask at 
doses up to 4 Gy, and 105 cells per flask at doses up 
to 8 Gy. 
In both cases there were a left shift of the curves 
towards lower radiation doses, the greatest shift being 
in the case of mitoxantrone added before irradiation 
(Fig 4.11). The dose modifying factor of the 
mitoxantrone added before and after irradiation at 
survival levels of 0.37 were 3.15 and 1.80 
respectively. At a survival leve1 of 0.1, the dose 
modifying factors of the mitoxantrone added before and 
after irradiation were 1.82 and 1.39 respectively. 
The experimentally determined response curves of 816 
melanoma cells exposed to 60co-gamma rays and to 
60co-gamma rays where mitoxantrone was added either 
before or after radiation were analysed according to 
the linear quadratic model, S = exp{-p(aD+SD 2 )} using a 
curve fitting programme. The values of pa and pa were 
computed to be as follows: 
(a) 60co-gamma irradiation only, 
pa = 0.0335 Gy- 1, pa = 0.0692 Gy- 2 
(b) 60co-gamma irradiation with mitoxantrone added 
after irradiation 
-1 pa = 0.5509 Gy , pa - - 0.0005 Gy-2 
(c) 60co-gamma irradiation with mitoxantrone added 
before irradiation 
-1 pa = 0.7214 Gy , ps 
.... 
= - 0.0088 Gy-.:. 
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t:i Controls (no treatment with mitoxantrone) 
0 Mitoxantrone added before irradiation 
0 Mitoxantrone added after irradiation 
2 4 6 8 10 Dose (Gy) 
Fig 4.11 Response curve for 816 melanoma cells exposed to 60co-gamma rays and 
mitoxantrone. 
Each point-represents the mean of not less than 3 values. SEMis 
indicated by the vertical bars. Curves were fitted by making use of 
the linear quadratic equation, S = exp{-p{aD+BD 2 )}. 
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4.1.8.1 Relationship between ATP content and volume of the CaNT 
tumours 
Adenosine-5•-triphosphate levels have been measured in 
CaNT tumours having the following ranges of volumes: 
50-150 mm3, 150-250 mm3, 250-350 mm3, 350-450 mm3 and 
450-550 mm3. The measurements of ATP content within 
the entire removed tumours always were made immediately 
after sacrifice of the animals. The result is 
presented in Fig 4.12. · 
Glucose-6-phosphate dehydrogenase activity 
Glucose 6-phosphate dehydrogenase activity in the CaNT 
tumour in CBA mice was measured: 
(a) in normoxic conditions. 
(b) in normoxic conditions after starvation for 72 hours. 
(c) in normoxic conditions following x-irradiation. 
{d) after clamping the tumours (hypoxic conditions). 
(e) after clamping the tumours following x-irradiation. 
Glucose-6-phosphate dehydrogenase was measured as well in 
Fib/t murine fibrosarcoma in WHT mice: 
{a) in normoxic conditions. 
(b) in normoxic conditions following x-irradiation. 
Glucose-6-phosphate dehydrogenase activity in CaNT tumours 
4.2.2.1 Glucose-6-phosphate dehydrogenase activity in CaNT 
tumours in normoxic conditions 
In the normoxic control tumour the mean activity 
from 35 determinations was 0.028 .! 0.003 "mol 
glucose-6-phosphate converted/min/mg protein. 
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4.2.2.2 Glucose-6-phosphate dehydrogenase activity in CaNT 
tumours in normoxic conditions after 72 hours of 
starvation 
The mean activity of the enzyme determinations was 
0.026 + 0.004 ~mol glucose-6-phosphate 
converted/min/mg protein. This was not 
significantly different from the value obtained in 
the normoxic control tumour (P > 0.7). 
4.2.2.3 Glucose-6-phosphate dehydrogenase activity in 
normoxic conditions following x-rays 
The effect of ionising radiation on 
Glucose-6-phosphate dehydrogenase activity was 
measured at 30 minutes, 1, 3, 4, 18, 20 and 48 
hours after a dose 10 Gy x-rays. 
An enzyme activity increase was noted by 30 
minutes after x-irradiation which was 
statistically significant (P < 0.05). The maximal 
increase was observed 1 hour after the x-ray dose 
of 10 Gy. This is shown in the Fig 4.13. 
4.2.2.4 Glucose-6-phosphate dehydrogenase activity after 
clamping CaNT tumours 
The enzyme activity after 15 minutes of clamping 
the tumours showed an increase of 1.36 times 
compared with the normoxic unirradiated control 
tumours (P < 0.025). Nine determinations were 
made. 
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4.2.2.5 Glucose-6-phosphate dehydrogenase activity after 
clamping the tumours' following x-irradiation 
The activity of the enzyme remained unchanged 
after 15 minutes of clamping the tumour, following 
x-irradiation (10 Gy), when the activity was 
compared with CaNT tumours clamped without 
radiation. 
Glucose-6-phosphate dehydrogenase activity in Fib/t 
tumours 
4.2.3.1 Glucose-6-phosphate dehydrogenase activity in 
Fib/t murine fibrosarcoma tumours in normoxic 
conditions 
In the normoxic control Fib/t murine fibrosarcoma 
tumours the mean activity from 5 determinations 
was 0.029 ~ 0.003 ~moles of glucose-6-phosphate 
converted/min/mg of protein. 
4.2.3.2 Glucose-6-phosphate dehydrogenase activity in 
normoxic conditions following x-irradiation 
The specific activity of G6P-DH activity was 
measured 1 hour after x-ray administration (100 
kVp, 10 Gy). The activity of the enzyme 
increased. This was statistically significant 
(P < 0.001) and is shown in Fig 4.14. 
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4.3.1 Phosphomannose isomerase activity 
Phosphomannose isomerase activity was measured in liver 
tissue and tumour tissue of CBA and WHT mice in 
normoxia, and results are presented in Table 4.6. 
Phosphornannose isomerase activit~ in CBA and WHT mice 
Strain Specific activity 
of Organ/tissue of extract 
Mouse (Units/mg/protein) 
CBA Liver 0.017 + 0.002 
WHT Liver 0.015 + 0.001 
CBA CaNT tumour O.Oi9 + 0.003 
WHT Fib/t tumour 0.013 + 0.002 
Units are expressed as ~mol mannose 6-phosphate converted per 
minute at 25°C under standard assay conditions. 
The mean value + SEM for 4 determinations of Phosphomannose 
isomerase activity in different tissue is given above. 
4.4.1 Isocitrate dehydrogenase activity 
The enzyme activity was measured under the different conditions 
of: 
(a) normoxia, 
(b) normoxia following x-irradiation (10 Gy), 
(c) after clamping the tumours (hypoxic conditions), 
(d) after clamping the tumours and then giving 
x-irradiation (10 Gy). 
4.5.1 
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4.4.2.1 Isocitrate dehydrogenase activity in normoxia 
The mean activity of the enzyme was 0.46 ~ 0.07 J.lmoles 
isocitrate converted/min/mg protein, as determined in 
31 tumours. 
4.4.2.2 Isocitrate dehydrogenase activity in normoxia following 
x-irradiation 
As is shown in Fig 4.15, the activity of isocitrate 
dehydrogenase in normoxic conditions increased after 
x-irradiation. The maximum increase was observed 3 
hours after receiving the 10 Gy x-irradiation. This 
was 1.46 times that of the control (P < 0.05}. 
4.4.2.3 Isocitrate dehydrogenase activity after clamping the 
tumours with and without x-irradiation 
In both conditions the specific activity of the enzyme 
in CaNT tumours, which was determined at 25°C, remained 
unchanged which compared with the control (unirradiated 
and normoxic conditions}(P > 0.8). Eleven 
determinations in each experiment were made (Fig 4.16). 
Tissue sulphydryl levels 
Tissue sulphydryl levels were determined in CaNT tumours ·in 
CBA mice and Rhabdomyosarcoma Rl tumours in WAG/Rij rats. 
Tissue sulphydryl levels of tumours was measured under: 
(a} normoxic conditions 
(b) after mice had been exposed to 8% and 12% oxygen for 72 
hours 
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(c) normoxic conditions following x-irradiation (100 KVp 
and 8 MV), with a dose of 10 Gy. 
(d) after clamping the tumours for 15 minutes. 
{e) after clamping the tumours followed by x-irradiation. 
4.5.2.1 Tissue sulphydryl levels in CaNT Tumours 
The results of the tissue sulphydryl levels are 
illustrated in Fig 4.17. No significant changes in 
tissue sulphydryl levels compared with controls 
(P > 0.8 in both cases) were observed when mice were 
exposed to 8% or 12% oxygen in nitrogen for 72 hours 
prior to assay. Also, no significant changes were 
observed after clamping of tumours, or x-irradiation 
with 10 Gy, or after 10 Gy x-irradiation and clamping 
(P > 0.8). 
4.5.2.2 Tissue sulphydryl levels in Rhabdomyosarcoma R1 
tumours 
Tissue sulphydryl levels were measured in 
Rhabdomyosarcoma R1 tumours, in normoxia and in 
normoxia 1 hour after a dose of 10 Gy BI~V x-rays using 
a Philips SL 75-20 linear accelerator. 
There was no significant difference between tumour 
tissue sulphydryl levels following the x-ray dose and 
controls (P > 0.7) as shown in Fig 4.18. 
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Controls 
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Fig 4.14 Glucose-6-phosphate dehydrogenase activity in Fib/t murine 
fibrosarcoma following x-irradiation. 
The heights of the histogram compartments represent the mean of not 
less than 7 determinations. The error bars shown represent the SEM. 
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Fig 4.16 Isocitrate dehydrogenase activity after clamping the tumours with and 
without x-irradiation. 
The heights of the histogram compartments represent the mean of not 
less than 11 determinations. The error bars shown represent the SEr1. 
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4.5.2.3 Glutathione (GSH) levels in deproteinized samples of 
CaNT tumours 
By using the enzymatic method of Tietze (179)· for 
quantitative determination of the amounts of total and 
oxidized glutathione, its level was measured in CaNT 
tumours. The mean + SEM of the GSH levels in 4 
/ 
unirradiated control tumours and in 4 tumours after 10 
Gy x-irradiation, in deproteinized samples were 1571 ~ 
0.082 ng GSH/mg tissue and 1633 : 0.054 ng GSH/mg 
tissue respectively. This result showed no significant 
difference (P > 0.8) in the levels of GSH between 
unirradiated tumour controls and irradiated tumours. 
The finding of no difference in glutathione levels 
between irradiated and non-irradiated tumours using a 
specific assay is similar to the finding where total 
thiols were assayed (4.5.2.1). 
4.5.2.4 Exogenous GSH added to CaNT samples and its 
guantitation 
To establish that glutathione extraction from tissue 
was quantitated, a fixed amount of GSH was added to the 
samples immediately after initial homogenization. Two 
different concentrations of GSH were added to the 
tumour samples: 500 ng and 1000 ng of GSH/mg tissue. 
The following procedures were performed and then the 
GSH levels assayed: 
(i) The CaNT tumours were removed from the CBA mice 
and cut into two pieces. 
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(ii) Tumour tissue was weighed out and homogenized 1:5 
w/v with ice cold homogenizing medium, which 
consisted of physiological saline {0.9 NaCl w/v) 
in 0.66 mM of EDTA. 
(iii) To the homogenate of one piece of tumour tissue 
was added 500 ng of GSH/mg of tissue. The other 
piece of the tumour was homogenized without 
adding extra GSH. The same procedure using a 
concentration of 1000 ng of GSH/mg tissue was 
followed in another tumour, similarly cut in two. 
(iv) To deproteinize all the samples 1 mt of 5% TCA 
was added. 
The results indicated that the GSH levels in the 
samples with exogenously added GSH {2279 and 2377 ng 
GSH/mg tissue) were equivalent to those added to the 
initial homogenates plus the endogenous GSH content 
(1773 and 1382 ng GSH/mg tissue). Thus the differences 
were 506 and 995 ng GSH/mg tissue respectively. These 
values are 101.2% and 99.5% of the added amounts of 500 
and 1000 ng GSH/mg tissue. 
4.5.2.5 Stability of glutathione in non-deproteinized 
homogenates 
A tumour extract was prepared as described in 3.5.1.1. 
Immediately after preparation the glutathione level was 
determined in 50 mt of a 1 in 100 dilution of the 
preparation, using the method described in 3.6.1.7. 
The preparation was stored on ice and glutathione 
levels were determined again at 0,1 and 4 hours. No 
detectable change in glutathione levels were measured 
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over the 4 hour period, indicating that glutathione 
remains stable in tissue homogenates over at least a 4 
hour period. 
4.6 Some Biological Effects of Magnetic Fields 
4.6.1 
4.6.2 
Growth rate 
The effects on growth rate of CaNT murine tumours in CBA 
mice, when exposed to magnetic fields of a Nuclear Magnetic 
resonance imager have been studied. Measurements were made 
with the tumours subject to: 
{a) Single exposure and split exposures in static magnetic 
field (0.5 Tesla). 
(b) Split exposure in static magnetic field {0.5 Tesla) 
plus a varying magnetic field 5 x 10-3 Tesla/m. 
Determinations of the growth rate with exposure to 
magnetic field 
Tumour diameters were measured in three perpendicular 
directions using Vernier calipers, and the tumour volume was 
calculated assuming tumours to be spherical. Mean tumour 
volumes at the beginning of each of the treatments were 170 
+ 29 mm 3 • CBA mice with CaNT tumours in the thorax were 
divided into 4 groups: 
Group 1 - Controls; Group 2 - Single exposure in static 
magnetic field for 62 hours; Group 3 - Split exposure in 
static magnetic field for 16 hours per day over 7 days and 
Group 4 - Split ~xposure in changing magnetic field 
(superimposed on static field 0.5 Tesla) fer 16 hours per 
day over 7 days. 
4.6.3 
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Retardation of the tumour growth was observed after exposure 
to static and dynamic magnetic gradient fields. The result 
is represented in Table 4.7. 
Significantly different tumour growth was seen in Groups 3 
and 4 when compared with Group 1 (P < 0.0010 and P < 0.0015 
respectively). Group 2 showed no significant difference 
compared with the controls. 
Evaluation of the volume doubling time when exposed to 
a magnetic field 
The mean tumour volume doubling time in controls (no exposure to 
magnetic field) was 71 ~ 8.1 hours (n = 12). In Groups 2, 3 and 
4, when compared with Group 1 (controls), it was noted that 
longer times were required to attain twice the initial tumour 
volume. This result is shown in Fig 4.19. 
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Fig 4.17 Tissue sulphydryl levels in CaNT tumours. 
The heights of the histogram compartments represent the mean of not 
less than 9 determinations. The error bars shown represent the SEM. 
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Fig 4.18 Tissue 'sulphydryl levels in Rhabdomyosarcoma R1 tumours after 
x-irradiation. 
The heights of the histogram compartments represent the mean of not 
less than 5 determinations. The error bars shown represent the SEM. 
TABLE 4.8 
CaNT tumour 
Group 1 
Group 2 
Group 3 
Group 4 
-----
Biomagnetic effects on growth rates 
n Magnetic Induction· Effects observed after 7 days 
12 
- Controls 
7 Static magnetic field 13.7% inhibition of 
tumour growth 
9 Static magnetic field 43.3% inhibition of 
tumour growth 
9 Dynamic magnetic 39.7% inhibition of 
gradient fields tumour growth 
~- --~- ----- ---- --- -· ----
--- -
..... 
N 
-.....! 
4.7.1 
4.8.1 
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Specific activities of Glucose 6-phosphate 
dehydrogenase and Phosphomannose isomerase in CaNT tumours 
exposed to magneti~ field 
The effects of magnetic fields upon specific activities of 
glucose-6-phosphate dehydrogenase and phosphomannose isomerase 
were measured after split exposures in superimposed static and 
pulsed magnetic field gradients (0.5 Tesla plus a varying 
magnetic field 5·x 10-5 Tesla/cm) for 16 hours per day over 7 
days (Group 4). The activities of the enzymes show no 
statistically significant difference after split exposures in 
magnetic fields. 
The result is presented in Fig 4.20. 
Measurements of T1 the spin lattice relaxation time and 
T2 the spin-spin relaxation time in CaNT tumours 
exposed to magnetic fields 
The effects of different exposures to a static magnetic field 
(0.5 Tesla) on Tl and T2 values of CaNT tumours in CBA mice were 
measured using controls and tumours exposed in the magnetic field 
for 16 hours per day over 7 days. 
The relaxation times T1 and T2 of CaNT tumours show no 
statistically significant difference (P > 0.8) after split 
exposures in the nuclear magnetic resonance imager. 
The following image shows the tumour in a rectangular region of 
interest (ROI) Fig 4.21. Centering the ROI on the tumour of each 
mouse in turn enabled the average of its relaxation times to be 
determined. The computer also calculated the standard deviation 
in each case (181). 
The result of the measurements is presented in Table 4.8. 
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Fig 4.19 Volume doubling time in CaNT tumours when exposed to a magnetic field. 
Mean tine (hours) ~ SEM for each group of tumours to reach 2 times the 
initial tumour volume. 
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TABLE 4.8: 
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NMRI: CaNT tumour in CBA mice 
Controls 
84.2 + 12.6 
2301 + 201 
Magnetic Field 
79.5 + 9.7 
2366 + 156 
4.9 Electron microscopy ultrastructural studies in CaNT tumours 
after x-irradiation 
n 
8 
8 
Electron microscopic ultrastructural studies were made of CaNT tumours in 
CBA mice before and after x- irradiation using doses of 10 and 100 Gy. 
Fig 4.21 A nuclear magnetic resonance image of a CBA mouse with CaNT tumour. 
(This image is used to calculate quantitative relaxation times and is 
not intended to demonstrate morphology). 
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No changes in representative electron micrographs of CaNT 
tumours, compared with control (Fig 4.22) (non-irradiated) 
tumours, could be observed after irradiation with 10 Gy (Fig 
4.23). However, after irradiation with 100 Gy morphological 
alterations were noted in the cell, with drops characteristic of 
lipid (Fig 4.24), probably released from rupture or disruption of 
organelles. There is also clear degeneration of the cristae and 
matrix of mitochondria in the tissue irradiated with 100 Gy (Fig 
4.25) compared with the control. 
Apart from cellular damage resulting from the radiation, which 
has been described above, another interesting feature was noted 
and thanks are due to Prof W Becker of the Department of 
Virology, University of Stellenbosch Medical School for 
assistance in the analysis of the micrographs. This was a series 
of round particles with a dense circular concentric interior 
region and a surrounding less dense ring (Fig 4.26). 
In a control tumour about 25 such particles were seen grouped 
together outside the cell membrane. In irradiated cells these 
particles were fewer and scattered, some within cisternae and in 
one case budding from the cell membrane (Fig 4.27). These 
particles have the typical apperance of a murine leukemia type C 
retrovirus with a dense nucleuid . The particle observed budding 
from a membrane is also characteristic of such viruses. They are 
frequently seen and are most likely to be an associated (not 
causative) finding in these tumours. 
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Fig 4.22 Electron micrograph of control CaNT tumour usi ng ma gnification 23000X. 
A typical regi on is shown with no difference between organelles and 
structure of th is image and those of Fig 4. 23. 
Fig 4.23 Electron micrograph of a typical region of a Ca NT tumour which has 
received 10 Gy of x-irradiation. The magnification is 23000X. There 
is no signifi cant difference from the control t umour. 
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Fig 4.24 Electron micrograph of a CaNT tumour which has received 100 Gy of 
x-irradiation. Lipid droplets are clearly visible as described in the 
text. The magnification is 49000X. 
Fig 4.25 Electron micrograph as for Fig 4.24, but showing disruption of 
mitochondrial structure as described in the text, using magnification 
23000X. 
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Fig 4.26 Electron micrograph of a control CaNT tumour showing viral particle 
inclusions, at magnification 23000X. 
Fig 4.27 Electron micrograph of a CaNT tumour which has received 100 Gy of 
x-irradiation. There .are fewer viral particles detectable and one 
particle budding from the cell membrane is clearly seen. The 
magnification is 23000X. 
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CHAPTER 5 
DISCUSSION 
Observable effects of radiant energy in living organisms include cell death, 
blockage of replication capacity, or induction of nonlethal alterations in 
macromolecules including enzymes and cell membranes (40, 55). 
The biological effects of radiation have been investigated in depth by a great 
many workers with the aim of gaining a greater understanding of the mechanisms 
of the nature of the cell killing process and by which radiation leads to tissue 
breakdown. 
Many studies have been in vitro, where mammalian and bacterial cells have been 
subjected to irradiation, and the cloning ability of survivors assessed using a 
conventional dose response curve (182). From these curves information can be 
obtained concerning radiosensitivity of various cell types, repair processes, 
and effects of changing physical conditions. The way in which these and other 
factors interact will ultimately determine the radiation response of organised 
normal tissues and tumours. 
The radiosensitivity of the many specialized forms of cell and tissue in the 
body varies widely. In general, cells are sensitive to radiant energy in direct 
proportion to their reproductive or mitotic activity and in inverse proportion 
to their level of specialization. 
Further information regarding the mechanism of radiation action can be obtained 
from biochemical studies following irradiation of biological material. In this 
thesis a number of metabolic parameters have been investigated following 
irradiation, with particular emphasis on energy production and energy utilizing 
processes in tumour cells. 
In particular this study investigates the possible interrelationship of 
adenosine-5'-triphosphate, glucose-6-phosphate dehydrogenase, isocitrate 
dehydrogenase, phosphomannose isomerase and glutathione in normoxic and hypoxic 
conditions following irradiation. 
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Neoplasms, which obviously include the tumours used in this study, viz CaNT, 
Fib/t, 3-MC-induced and Rl, consist of a complicated heterogeneous population of 
dividing cells, non-dividing cells, oxic cells, hypoxic cells and necrotic 
ce 11 s. 
As a result the radiation sensitivity of the tumour will vary with the different 
cell populations. For example Gray et al (183) provided experimental evidence 
to show that hypoxic ce 11 s are about three times more resistant to x-rays than 
oxygenated cells. 
In addition, it should be noted that during clonal amplification in tumours, a 
series of additional phenotype changes (184) occur which are related to the 
regulation of growth and differentiation as well as to the continual 
environmental and physiological changes, which may lead to inhibition of 
intercellular communication and modification of biochemical response (185). 
Therefore the heterogenous tumour cell population consequently undergoes a 
disturbance of homeostatically regulated growth. These phenomena are 
multifactorial and not fully understood (186). 
It is of interest to note that several in vitro studies have suggested that 
radiation sensitivity can be altered by modification of the energy state of the 
cell (187, 188). Although as discussed above, the tumour is a more complicated 
system, the potential does exist for changing the energy state of tumours, an 
approach which may lead to the development of novel strategies for tumour 
radiosensitization. 
Adenosine-5'-triphosphate appears to play an important role in repair mechanisms 
including cellular repair following radiation damage (189, 190). The 
relationship between ATP yield and repair processes remains unclear in cell 
metabolism. 
A very important and relevant repair process is that of DNA. A general 
mechanism for repair involves removal of a segment of a damaged strand, with t~e 
gap then filled by the action of DNA polymerases, followed by the. action of DNA 
ligases (191). 
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The key to all the repair or recombination processes is the initial recognition 
of the defect. One or more enzymes will combine with a DNA strand containing 
deletions, strand crosslinks or other abnormal base constituents and hydrolyze 
the polynucleotide backbone adjacent to the defect. After the DNA strand is 
broken, exonucleases remove the defective residues. The gap is then filled by 
DNA polymerases and finally closed by DNA ligases (192, 193). These enzymes 
participate in DNA replication and repair pathways in both prokaryotes and 
eukaryotes. The 3'-5' phosphodiester bond generated by DNA ligase restores the 
integrity to DNA strands following replication and repair. 
The relationship of ATP to DNA repair has been studied by several workers who 
have shown that some of the enzyme steps require ATP, e.g. normal diploid human 
fibroblasts (AG 1518), xeroderma pigmentosum fibroblasts group G (194, 195), 
Escherichia coli and calf thymus cells. 
It has been suggested by some authors that ATP is associated with cell membrane 
repair following ionizing radiation (18, 19). For example, conformational 
changes in the cytoplasmic membrane due to ATP-dependent polymerising proteins 
have been described (17). 
·Adenosine-5'-triphosphate has also been shown to modify the ionizing radiation 
response in several situations. Tikhomirova et al (196) have demonstrated that 
ATP protects against high energy protons. The survival of CBA and CS7B1 hybrid 
F1 mice treated with ATP and irradiated throughout the whole body with 9 GeV 
protons was reported to have been increased from 63 to 80%. 
Nikolov et al (197) also have shown that ATP administration provides protection 
for monkeys (Macaca mulatta) against a dose of 8.3 Gy gamma irradiation {137cs). 
The survival in control groups was only 5% and after ATP administration (two 
injections of 37 mg kg- 1 body weight) was 5mb. (The previous two references 
(196, 197) were available only in the form of abstracts). 
Nishizawa et al (23) investigated the effect of ATP deprivation by 2,4 
dinitrophenol {DNP) in murine melanoma cells in culture on the x-radiation 
response of these cells. The survival curves were changed as a result of post 
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irradiation treatment with DNP, with a diminished shoulder (implying less 
radiation damage repair) and also a decreased extrapolation number (n). 
Experiments were conducted concerned with the protection of C57BL male mice from 
genetic radiation damage in germ-cell genetic structures, using a combination of 
adenosine-5'-triphosphate, aminoethylisothiuronium Br-HBr (AET) and serotonin 
(188, 189). Such a combination was found to reduce, by a factor of 2, the 
metaphases with translocations observed after 3 and 4 Gy x-rays to mouse 
spermatogonia compared with irradiated mice not receiving the combination. 
Removal of ATP from the combination led to a significant reduction {59%) in 
protective effect. These findings indicate that there might be a role for ATP 
in repair systems. The authors emphasize that this high energy phosphate 
compound should be considered as an essential component in selecting 
combinations of agents intended to protect against genetic radiation injuries. 
There are several examples which show the ATP pool increases in cell metabolism 
after different types of radiation both "in vitro" and "in vivo". Barbe et al 
(198) have reported that UV-irradiation of Escherichia coli induces a two fold 
increase in the ATP pool. The ATP augmentation is .dependant on exonuclease 
activity, which suggests there exists a relationship between DNA damage repair 
and the increase in ATP levels. Passarella et al (199) have shown that there is 
' 
an increase of proton electrochemical potential and ATP synthesis in Wistar rat 
liver mitochondria, irradiated in vivo by a helium-neon laser. Irradiation was 
carried out with a power of 15 mW to give an energy dose of 5J/cm2 • An 
explanation was given in terms of the radiation-induced electron transfer giving 
rise to proton translocation and changes in the redox state of mitochondrial 
coenzymes and subsequently increases in ATP yield. Sijens et al {200) have 
reported a study of the response of a murine mammary tumour after 60co gamma 
radiation. The effect on the implanted murine mammary carcinoma NU-82 in DBA-2 
strain mice, to 10 Gy of gamma radiation was followed by an in vivo 31 P-nuclear 
magnetic resonance spectroscopy study. During the first Sh after the dose of 10 
Gy, the ratio ATP/inorganic phosphate increased to a value of 120 + 15% {SE) of 
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the control value. One of the authors• hypotheses is that increased ATP 
consumption is related to repair of radiation damage, and in particular to 
restore damaged membranes. In the present research work the levels of ATP in 
the transplantable CaNT murine tumours grown in CBA mice, rhabdomyosarcoma 
tumours in Balb C mice, and Fib/t fibrosarcoma in WHT mice, were increased at 
various times following x-rays and 60co gamma radiation as presented in Chapter 
4. In fact, as well as in 816 melanoma cells in culture, the largest increase 
in ATP levels noted, viz 3.8 times that of controls 2.5h following 10 Gy (201) 
is most considerable. Nevertheless very high doses, viz 100 or 200 Gy would be 
expected to sterilize the tumour, with little or no resultant r~pairable damage. 
If then, ATP was involved in damage repair, it would not be expected for ATP 
levels to increase following these doses. Indeed this was observed in the CaNT 
tumour. It is suggested that the increased ATP content after irradiation may 
play a major role in energy provision when cellular repair processes are able to 
operate. 
A clear montonically decreasing trend is seen in the variation of CaNT mouse 
·tumour ATP content, as a percentage of control values, with increasing photon 
energy using equal doses of 10 Gy (Chapter 4, Section 4.1.6.1). It must be 
emphasised that the processes of interaction differ at the different photon 
energies, for example because the microscopic range of reaction products depends 
on incident photon energy. Further, as has already been explained in Chapter 2, 
(Section 2~2), the relative cross sections for the different interaction 
mechanisms vary by several orders of magnitude over the range of photon energy 
applied (0.1 to 8.0 MeV). Therefore with the highest incident energies used, 
the biochemical effects of the interactions of this ionizing radiation must 
differ in nature and spatial distribution from the lowest. Possibly when there 
is a more extensive energy deposition within the cell more damage might be 
suffered by the repair mechanism and the production and control responses using 
ATP. This may explain the tendency to lesser ATP yield in tumour tissue subject 
to higher photon energies. 
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It is interesting to note that other adenosine phosphates may be involved in DNA 
repair processes following ionizing radiation. For example, Vikhauskaia et al 
(202) showed repair of single stranded DNA breaks in CHO-Kl cells resulting from· 
x-irradiation could be stimulated by treatment of the cells with isoproterenol. 
This latter treatment increased cellular cAMP. (The previous reference was 
available only in the form of an abstract). 
Further, cAMP stimulating agents given before x-irradiation increased the 
survival of irradiated V-79 cells (203, 204) and thymocytes (205) in culture. 
In vivo studies by Langendorff et al (206) demonstrated that cAMP together with 
ATP provided a significant degree of protection in irradiated mice, but cAMP 
alone was ineffective. (Interestingly, ATP alone provided about a 44% degree of 
protection, compared with the combinatiori of cAMP and ATP which gave 70%). Low 
dose (0.15 Gy) x-irradiation of Chinese hamster fibroblast cells has been show~ 
to increase significantly intracellular cAMP levels without any hormonal 
stimulation (207). It has also been suggested that irradiation activates 
membrane bound enzymes which mediate conformational changes in the cell membrane 
structure. This may result in beta-adrenergic activation of adenylate cyclase, 
with subsequent augmentation of cAMP levels. 
Sarkav et al (208) have exposed male Sprague Dawley rats to \'/hole body 60co 
gamma radiation (4 and 10 Gy) without exogenous stimulation. The results show a 
significant increase in myocardial adenyl ate cyclase with simultaneous decrease 
of phosphodiesterase activity, indicating indirectly an increase in cAMP. This 
study indicates that even without a hormonal stimulating treatment, activation 
of myocardial adenylate cyclase occurs by some endogenous modulatot·, probably as 
a mechanism for radiation protection. 
Cyclic AMP acts as a second messenger in conveying a signal to responsive 
enzymes within the cell.· It is possible that radiation modifies coupling 
between.receptors and adenylate cyclase. As a result of radiation, then there 
may be an amplification of the initial signal. It may be useful at this stage 
to consider this concept in more detail. Cyclic AMP is known to take part in 
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the regulation of carbohydrate metabolism by promoting glycogenolysis and 
glycolysis and by inhibiting glycogen synthetase. When a living organism is 
confronted with an emergency (e.g. stress by radiation) that may demand prompt 
energy production increase, it must mobilize glucose rapidly from glycogen to 
have the fuel available. Cyclic AMP acts as a 11 second messenger 11 conveying the 
signal received on the receptors of the plasma membrane which triggers an 
intracellular cascade of enzyme activation to accelerate formation of glucose 
from glycogen (209). The cell then metabolizes the glucose to supply free 
energy (ATP) and maintains homeostasis after injury in response to the 
radiation. This may be the mechanism which explains the ATP increases noted in 
this work. This chain of events may be controlled by a feedback mechanism that 
helps the cells to defend themselves against injuries. Most of ATP yield is 
produced in the mitochondria and is transported across the inner mitochondrial 
membrane to the cytosol by a carrier or antiporter translocase system (adenine 
nucleotide translocase). 
Energy transport is one of the central problems in the thermodynamic balance in 
living organism. The crucial role of creatine phosphokinase in the requirement 
for a high flux of high energy phosphate from the inner mitochondrial membrane 
to the medium surrounding the mitochondria is supported by numerous 
physiological studies (210, 211). According to Dzeja et a1 (212) mitochondrial 
and cytoplasmic isoenzymes of adenylate kinase can act in parallel with creatine 
phosphokinase isoenzymes in ATP energy transmission from the mitochondria to the 
localized sites of energy demand in the cytoplasm. If there is a low activity 
of creatine phosphokinase, adenylate kinase can perform this function 
independently. Another function of adenylate kinase isoenzymes is to cause a 
decrease in the difference of the phosphate potential and Gibbs free energy of 
ATP hydrolysis. This implies that energy transport would proceed with an 
increased efficiency and reduced energy transmission losses (entropy) when 
adenylate kinase controls the energy flux. 
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The ~ugmentation of the protons• movement from the inside to the outside of the 
mitochondrial membrane, due to acceleration of glucose catabolism in the Krebs 
cycle, may be result in a change of the redox state of mitochondrial coenzymes 
(213), creating an extra-electrochemical gradient which would then be involved 
in the generation of ATP. 
Thus far, the discussion has centred on ATP changes following radiation, 
radiation sensitization as a result of ATP depriviation, radiation protective 
effects of exogenous ATP, the relationship of cAMP to ATP, and it has been 
suggested that perhaps ATP increases following x-irradiation may provide energy 
to repair radiation damage. However, it is enlightening to consider the ATP 
increases following radiation from a biophysical/thermodynamical point of view. 
The radiation processes increment the disorders by augmentation of random 
fluctuations in biological systems. Normally the cell is said to be in a 
homeostatic 11 Steady state 11 able to handle physiological demands. Radiation 
damage may bring about a number of cellular adaptations in which a new but 
altered steady state is achieved, but in which the cell remains viable. One can 
consider the cell to have an indefinite number of steady states. Consequently 
when the cell is still alive and it tries to maintain order in its constituent 
matter, it takes negative entropy from the environment. These negentropic 
phenomena permit the cell to fight against the irreversible processes of 
increasing disorder after radiation injury. Therefore in the cells, radiation 
damage represents residual uncertainty about the biophysical system after an 
ordering effect in the number of radiation induced disturbances. 
Whether specific types of stress such as ionizing radiation or magnetic field 
induce an adaptive response, as repairable injury, or cell death, depends on the 
nature and severity of the lesion, and on many other variables relating to the 
intrinsic state of energy metabolism. In other words repair is the capability 
to 11 Capture 11 negentropic organization against the random variations produced at 
the biochemical level to obtain order. Thi$ occurs at the expense of the order 
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of the surrounding medium. An isolated system is subject to processes that do 
not violate the second principle of thermodynamics (214). 
It has been shown in Chapter 4, Section 4.1.3.1 that tumour ATP levels are 
decreased to 78 and 75% (215) of control levels after 15 minutes and 2 hours of 
tumour clamping. (This procedure produces radiobiological hypoxia (216)). The· 
sequence of events in hypoxic injury has been studied by a number of authors in 
experimental animals and in tissue culture sytems (217, 218, 219). The first 
point of attack of hypoxia is the cell's aerobic respiration i.e., oxidative 
phosphorylation by mitochondria (220, 221). As the oxygen tension within the 
cell decreases, there is a decrease of oxidative phosphorylation and of ATP 
generation. There is inhibition of the electron transfer system coupled to 
oxidative phosphorylation in the mitochondria and therefore intereference with 
ATP synthesis (222). 
The decrease in cellular ATP and associated increase in AMP stimulates the 
enzyme phosphofructokinase, which results in an increased rate of anaerobic 
glycolysis to maintain the cell's energy sources by generating ATP from glycogen 
(223). Glycolysis results in the accumulation of lactic acid and inorganic 
phosphates from the hydrolysis of phosphate esters (224, 225). This reduces the 
intracellular pH (226). 
Nagle et a1 (187) have reported the effects of 5-thio-D-glucose (5-SH-D-Glc) on 
cellular ATP levels and DNA rejoining in hypoxic and aerobic Chinese hamster 
fibroblasts. Intracellular ATP levels were measured in both hypoxic and aerobic 
cultures of V79 Chinese hamster cells treated with 5-SH-D-Glc. This glucose 
analogue, a known inhibitor of D-glucose transport and metabolism, reduced ATP 
in cell cultures which were allowed to become hypoxic, but not in aerobic 
cultures treated with this compound. Cells depleted in ATP were unable to 
rejoin x-ray induced DNA strand breaks. The 5-SH-D-Glc leads to reduced energy 
metabolism in cells dependent on glycolysis for ATP production. The inference 
for radiation therapy (226) is that inhibition of glucose metabolism by this 
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drug selectively depletes energy reserves in hypo~ic cells, rendering th~se 
cells more radiosensitive and leading to a more effective tumour treatment. 
The requirement of glucose for the production of ATP in mammalian cells was 
reported by Matsudaria et al (227) who used Ehrlich ascites cells in vitro 
suspended in phosphate-buffered saline (PBS) with or without SmM of glucose. 
When these cultures were made anaerobic by gassing with N2, cellular ATP in the 
absence of glucose decreased to about 15% of that in aerobic cells. Freudenberg 
et al (228) reported a 90% reduction in intracellular ATP in anaerobic cultures 
of rabbit reticulocytes in vitro. Matsudaria et al (229) also observed that 
glucose-free anaerobic cultures of Ehrlich cells in PBS did not rejoin 
.x-ray-induced DNA strand breaks, whereas rejoining did occur under N2 when 
glucose was present. It appears that ATP is necessary to support rejoining of 
DNA. 5-thio-D-glucose effectively inhibits 0-glucose metabolism and as a 
consequence, cellular ATP was reduced and DNA rejoining inhibited (226). The 
cellular dependence on ATP for the rejoining of ionizing radiation induced DNA 
single-strand breaks has been presumed to result from the involvement of .DNA 
ligase (230) which requires ATP as a cofactor. Guanosine-triphosphate or.other 
high energy phosphate compounds do not function in this capacity (231). 
Therefore, ligation of DNA strand breaks would not be possible in cells depleted 
of ATP regardless of which ligase was required for this repair. More work must 
be done to establish the identity of the repair DNA ligase and to quantitate 
further its ATP dependence in irradiated cells. The DNA degradation observed by 
Song et al (232) in hypoxic cells after addition of 5-SH-0-Glc, may have been a 
consequence of the cytotoxicity of the 5-thio-D-glucose for· hypoxic cells, 
rather than energy deprivation. Hypoxic cells, which are most dependent on , 
t 
anaerobic glycolysis for energy production, were reported by Nagle et al (187), 
to become severely depleted in energy (ATP) when this process is inhibited by 
interference with glucose metabolism. The energy depleted hypoxic cells 
produced a deficiency in DNA repair capability. Therefore a transient inhibitor 
of tumour cell glycolysis combined with irradiation could selectively sensitize 
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the hypoxic cells, and thereby lead to therapeutic advantages. The levels of 
ATP following x-irradiation during experimental hypoxia in CaNT tumours were 
investigated. The decrease of ATP content to 78 and 75% (Chapter 4, Section 
4.1.3.1) with respect to the controls can be associated with impaired nutrient 
blood flow and diminished oxygen consumption in the tumour. Adenine nucleotide 
translocase, is an antiport localized on the inner mitochondrial membrane. It 
is a carrier with a molecule-for-molecule exchange of ATP and ADP. In this 
manner it confers the specificity of oxidative phosphorylation and controls the 
ratio of ATP/(ADP +Pi) or phosphate potential of the cell. Any disruption, 
such as the diminished oxygen consumption in normally coupled mitochondria, 
would immediately be reflected in a lack of energy balance between the metabolic 
processes of the intra- and extra-mitochondrial compartments of the cells. This 
leads to interference with ATP synthesis. Consequently under these conditions 
uncoupled oxidative phosphorylation in the mitochondria with a reduced ATP 
yield, is unable to generate any response related to repair processes following . 
radiation damage. 
ATP content of control CaNT tumours grown in CBA mice was measured for different 
ranges of tumour masses. It is clear there is an inverse relation between ATP 
content per unit mass of tumour and total tumour mass (Chapter 4, Section 
4.1.8.1). This finding most likely reflects the well-known association between 
tumour size ar1d degree of necrosis (182). This correlation has been confirmed 
and analysed for individual rods of tumour cells using diffusion theory for 
oxygen penetration from capillaries and histological observations. 
The effect of ionizing radiation on glucose-6-phosphate dehydrogenase activity 
in normoxic conditions was determined at different times after the x-irradiation 
in CaNT tumours in CBA mice and Fib/t murine fibrosarcomas in WHT mice. The 
activity of the enzyme increased after these tumours received 10 Gy x-rays and 
the results are described in Chapter 4, Sections 4.2.2.3 and 4.2.3.2. 
Major functions of the pentose phosphate pathway are to provide NADPH for 
reductive synthesis outside the mitochondria and to provide ribose for 
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nucleotide and nucleic acid synthesis. Glucose-6-phosphate dehydrogenase 
catalyzes the initial and rate-limiting step of the pathway that is the 
principal source of cytoplasmic NADPH in the cell. Engstrom et al (233) have 
evaluated the early effect of local x-irradiation with moderate doses to the 
epiphysis of the tibial bone in rats. The activity of glucose-6-phosphate 
dehydrogenase was analysed and related to the morphology of the epiphyseal 
cartilage and metaphyseal bone in irradiated animals. Increased activity was 
noted for glucose-6-phosphate dehydrogenase especially after 8 and 10 Gy, and an 
increased number of osteoclasts was noted in morphological observation. The 
increased enZJ'me activity in the epiphyseal cartilage was suggested to 
correspond to a cellular demand for an increased metabolism through the pentose 
phosphate shunt and stimulates the proliferation and number of osteoclasts. The 
temporary enhancement of this enzyme might be due to a demand of restitution of 
a diminished cell population caused by the cell death or inhibition of cell 
division after irradiation. 
According to an abstract obtained from a literature database, Savitsky et al 
(27) have shown changes in fructosediphosphate aldolase and glucose-6-phosphate 
dehydrogenase activity in brain, liver, myocardium and skeletal muscle after 
irradiation of rats with a single whole body dose of gamma irradiation (10 Gy). 
The activity of fructosediphosphate aldolase was mainly inhibited and that of 
glucose-6-phosphate dehydrogenase increased. In other words the initial step of 
glycolysis was significantly inhibited and the first reaction step of the 
pentose phosphate pathway enhanced in the irradiated body. The augmentation of 
the pentose phosphate pathway indicated by the increased glucose-6-phosphate 
dehydrogenase may be indirectly indicative of stimulated cell proliferation and 
repair processes after radiation damage. 
Gupta et al (234, 235) have also shown that ionizing radiation results in an 
increase in glucose-6-phosphate dehydrogenase activity. These workers exposed 
(partial body) rats to a dose of 2 Gy gamma irradiation, and showed an increased 
activity of the NADPH linked glucose-6-phosphate dehydrogenase in non-germinal 
- 148 -
cells of the rat testis. It was proposed (234, 235) that the increased 
glucose-6-phosphate dehydrogenase activity was due to an increased amount of the 
enzyme as a result of an increased rate of RNA synthesis. 
From the foregoing evidence, it is proposed in this thesis that the augmentation 
of glucose-6-phosphate dehydrogenase following ionizing radiation is an 
indicator of the response to injury, and may trigger the repair of lesions at 
the biochemical level. This augmentation can be envisaged to be part of the 
homeostatic regulation during the demand for increased metabolism. The results 
can also support the interpretation that the radiation induced increase of 
glucose-6-phosphate dehydrogenase is due to enhanced transcription of that 
genetic information to yield those products required for repair processes. 
The effect of ionizing radiation on isocitrate dehydrogenase (ICDH) activity in 
normoxic conditions also was determined at different times following 10 Gy 
x-irradiation in CaNT tumours. The activity of the enzyme increased in the 
tumour, after exposure to this ionizing radiation (215). The detailed results 
are giver. in Chapter 4. 
As mentioned previously the glucose-6-phosphate dehydrogenase mediated reaction 
. ' 
is a source of reducing equivalents. Anoth~r source is in fact from the 
isocitrate dehydrogenase reaction. The increase in normoxic conditions 
following radiation may be a reflection of the increased biosynthetic metabolism 
required for repair of radiation-induced damage. It is also interesting that 
the increased reducing equivalents generated by these enzymes under injury 
conditions may give protection against further damage due to peroxidative 
processes (236). 
In this thesis, the determination of the levels of tumour glucose-6-phosphate 
and isocitrate dehydrogenase under normoxic conditions and under hypoxic 
conditions following irradiation have been described (Chapter 4, Sections 
4.2.2.4, 4.2.2.5, 4.4.2.3). In the case of glucose-6-phosphate dehydrogenase, 
hypoxia for 15 minutes resulted in a significant increase (about 36%j compared 
with normoxic controls. When tumours were irradiated under hypoxic conditions, 
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the activity of glucose-6-phosphate dehydrogenase was not increased above the 
levels seen in hypoxic conditions only. This should be contrasted with the 
results seen following irradiation in normoxic conditions, where an increase of 
about 1.5 fold was observed. Tumour isocitrate dehydrogenase activity remained 
unchanged, compared with the controls, in hypoxic conditions, both with and 
without x-irradiation. These results are described in Chapter 4, Section 
4.4.2.3. 
Glucose-6-phosphate dehydrogenase is involved in anaerobic metabolism (237). It 
has also been clearly demonstrated that when the oxygen supply is inadequate, 
glucose production increases resulting from accelerated glycogen breakdown. The 
reason for this is that glycolysis can now compensate to some extent for the 
decreased energy production in the mitochondria in the citric acid cycle as a 
result of diminished oxygen. There is also an almost immediate rise in hexose 
monophosphate production, for example, when the coronary artery in conventional 
open chest dog preparations was occluded (237). Pyruvate oxidation and 
mitochondrial respiration undoubtedly occur in the moderately hypoxic state, but 
this is limited by oxygen availability rather than availability of ADP, 
phosphate, NADH and NADPH. 
In this investigation, the ability of the tumour cell to coordinate the rate of 
glycolysis in hypoxia, with subsequent metabolic demand in the activity of 
G-6-PDH, may be an important indicator of cellular biochemical integrity. The 
increase of flux in the glycolytic anaerobic pathway is related to a homeostatic 
feed back regulation in the hypoxic cell, to maintain metabolic integrity. 
Anaerobic glycolysis increments the activity of cytosolic enzymes (238). As 
discussed above, this is concomitant with the depletion of ATP production in th~ 
mitochondria due to deficiency in the oxygen supply in the Krebs cycle. The 
onset of increased activity of G-6-PDH occurs simultaneously with the onset of 
high-energy phosphate depletion. 
This is demonstrated by the findings reported in this thesis, where hypoxia 
resulted in a decrease of tumour ATP levels (Chapter 4, Section 4.1.3.1) with a 
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concomitant increase in glucose-6-phosphate dehydrogenase activity. Total 
levels of NADP-linked ICDH were shown not to differ significantly, with respect 
to the controls, in hypoxic conditions. This finding may be due to the fact 
that part of the total enzyme activity is located in the cytosol and part in the 
mitochondria (239). Therefore the depletion of ICDH activity in the 
mitochondria due to deficiency in the oxygen supply, could be compensated for by 
an increase of the ICDH activity in the cytosol. Zalewska et al (240) have 
conducted an experiment related to energj' utilization and changes in some 
intermediates of glucose metabolism in hypoxic rat brain. Lactate levels rose 
over four-fold. Pyruvate, glucose and glucose-6-phosphate concentrations also 
increased significantly. Metabolic activity in the cortex, expressed as the 
utilization of high-energy phosphates, decreased by 30% after the hypoxia and 
-
remained lowered for 3 hours during recovery. This was accompanied by an 
elevated glucose consumption and lactate production. These authors suggested 
that the maintenance of the energy balance during hypoxia was partly due to 
activation of the glycolytic pathway. During the recovery period, these 
metabolic abnormalities returned towards control values, but, after 6 hours of 
recovery the high-energy phosphate utilization increased transitorily above the 
control values. All these results are in accord with the experimental 
measurements of glucose-6-phosphate dehydrogenase, isocitrate dehydrogenase and 
ATP in hypoxic conditions described in this work. 
The next biochemical component that will be discussed is glutathione. It exists 
in virtually all living cells in either a reduced (GSH) or oxidized (GSSH) form. 
The biosynthesis of GSH has been demonstrated to be catalyzed by two enzymes: 
gamma-glutamylcysteine synthetase and glutathione synthetase (241). The recent 
introduction of drugs which specifically deplete (buthione sulfoximine (BSO)) 
(242) or elevate (2-oxothiazolidine-4-carboxylate (OZT)) (243) cellular 
glutathione levels has prompted a number of studies reexamining the role of GSH 
in the cellular response to ionizing radiation. Buthionine sulfoximine (BSO) 
depletes GSH by inhibition of gamma-glutamylcysteine synthetase (242). On the 
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other hand, OTZ stimulates GSH synthesis by providing high levels of 
intracellular cysteine (243). What is not fully appreciated is whether these 
compounds exert other cellular effects, which might complicate the 
interpretation of x-ray response data. In marked contrast to other agents, 
which have been used to deplete GSH such as diamide (244) and diethyl maleate 
(OEM) (245), no major non-specific cellular effects for GSH depletion by brief 
exposure to BSO have been reported. The major interest is defining GSH 
involvement in the response to ionizing radiation, stemmed from the free 
radical-scavenging hypothesis (246), which proposed that sulfhydryls, such as 
GSH, particularly at low oxygen tension, would play an important role in the 
response to ionizing radiation. 
Reports describing use of OEM to deplete GSH to low levels have indicated a 
substantial reduction in the oxygen enhancement ratio (OER). In other words GSH 
depletion produced dose-modifying radiosensitization of hypoxic cells (247, 
248). In contrast, there have been several reports where GSH was depleted by 
OEM or BSO treatment (249, 250) and sensitization of both aerated and hypoxic 
cells was observed and no net changes in the OER were seen. All of the above 
studies have sought to assess the role of sulfhydryls in radiation response by 
GSH depletion. However, discussion of studies directed toward elevation of GSH 
levels and subsequent assessment of possible protection should be instructive. 
OTZ provides an ideal intracellular cysteine delivery system that stimulates GSH 
synthesis. An effect of OTZ treatment, that of subsequent elevation in GSH 
levels to 200-300% of control levels, has been reported for aerated cells (251, 
252). Jensen et al (252) showed modest radioprotection with OTZ, whereas Russo 
et al (251) observed no protection. 
In this thesis tissue sulphydryl levels were determined in CaNT tumours in CBA 
mice and Rhabdomyosarcoma Rl tumours in WAG/Rij rats under normoxic conditions 
following x-irradiation (100 KVp and 8 MV) with a dose of 10 Gy. Determinations 
were also made after clamping the tumours for 15 minutes with or without 
x-irradiation. Further tumour sulphydryl levels were determined in CaNT tumours 
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after the tumour bearing mice were kept in 8% and 12% oxygen at one atmosphere 
total pressure for 72 hours. No significant changes in tumour sulphydryl 
levels, compared with the controls, were observed following any of the 
manipulations. 
The results are described in Chapter 4, Sections 4.5.2.1 to 4.5.2.5. It. is also 
important to note that when glutathione was specifically measured in 
deproteinized tumour tissue samples, there was no difference in levels between 
controls and in tumours that had been exposed to prior irradiation. This result 
is similar to that obtained when tissue sulphydryl levels were determined, as 
opposed to glutathione specifically. It is probable that the tissue sulphydryl 
levels measured in this work provide a good indication of glutathione levels. 
Wolters et al (253) have conducted an investigation related to the 
radiosensitivity of normal and polyunsatured fatty and supplemented mouse 
fibroblasts, after depletion of glutathione by OEM. The polyunsaturated fatty 
acids were introduced into the cells by incubating exponentially growing cells 
in a medium supplemented with 100 ~M eicosatetraenoic acid complexed to 25 ~M 
fatty acid free bovine serum albumin (BSA). The treatment resulted in 
modification of the phospholipid composition in all subcellular fractions of the 
fibroblasts, including the nuclear membrane. The content of polyunsaturated 
fatty acids was significantly increased, but no difference in cell survival 
after x-irradiation could be observed between the normal and polyunsaturated 
fatty acids enriched cells. It was concluded that although there are 
radiosensitive polyunsaturated fatty acids in the membranes, the cells are well 
protected against radiation damage. The content of GSH was approximately the 
same in the normal and the modified cells. Reduction of the cellular GSH 
content by more than 95 per cent using DEM did not alter cellular survival after 
radiation of either normal or polyunsaturated fatty acid enriched cells under 
oxic or anoxic conditions. The radiosensitive lipids present in the membranes 
of the polyunsaturated fatty acid enriched cells proved to be vulnerable to 
radiation-induced lipid peroxidation when extracted from the cells and 
- 153 -
reconstituted into liposomes, indicating that the fatty acids per se are 
peroxidizable. The authors (252) concluded that the lipids in the membranes of 
mammalian cells are not the principal target in radiation-induced reproductive 
death. Also no generalization is possible with respect to glutathione, being 
the major hydrogen donating species in mammalian cells responsible for the 
repair of those target molecules concerned with cell survival after radiation. 
This evidence complements conclusions drawn from the work of this thesis that 
endogenous GSH levels do not change after x-irradiation under normoxic 
conditions. However, this finding does not preclude GSH from being involved in 
cellular repair processes following irradiation. 
The next stage of the discussion refers to some of the effects produced by 
mitoxantrone. As has been demonstrated in this thesis, when tumours and cells 
in culture are exposed to ionizing radiation in normoxic conditions ATP levels 
were subsequently increased (Chapter 4, Sections 4.1.4.1, 4.1.4.2, 4.1.4.3). If 
the increased ATP reflects an increased demand for energy for cellular repair 
following irradiation, then by blocking this increase in ATP it may be possible 
to enhance the radiosensitivity of tumour cells (254). Neri et al (148) have 
shown that mitoxantrone may be a useful agent in this regard. Biochemical 
evidence suggests that mitoxantrone causes profound changes in chromatin 
structures including compaction (255). Mitoxantrone intercalates with DNA and 
shows preferential binding with guanine and cytosine causing a partial unwinding 
(256). Evidence from x-ray diffraction studies also suggests that there is an · 
additional external binriing component. 
In an experiment performed by Neri et al (148), it was demonstrated that 
mitoxantrone produces significant impairment of respiratory control in Wistar 
rat heart cells (oxygen uptake reduced by 46%) and a marked decrease (86%) of 
ATP concentration after one hour of exposure to the drug. 
This finding is consistent with the results obtained in this work both in vivo 
and in vitro. In this investigation ATP content in CaNT tumours after treatment 
with mitoxantrone was reduced by 11% compared with the controls. A more marked 
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decrease was noted in vitro, where ATP content of 816 cells after exposure to 
. . 
the drug was reduced by 26% (Chapter 4, Sections 4.1.5.1, 4.1.7.2). 
The mechanism by which mitoxantrone inhibits oxygen uptake and reduces ATP yield 
has not been adequately explained. It was suggested that the depletion of 
oxygen uptake caused by mitoxantrone results in inhibition of oxidative 
phosphorylation and therefore interferes with. generation of ATP (148). 
Meanwhile there is less outward pumping of protons due to deranged mitochondrial 
respiration. In the study of the effect of 0.5~g/ml· mitoxantrone on the 
radiation dose response of 816 melanoma cells in vitro, a radiosensitization 
effect was seen. The curves were analysed using the linear quadratic model. a~d 
it was of interest to note that the B coefficients for the curves in the 
presence of mitoxantrone were very small. This implies that the a component is 
more important, and the dose response curve tends towards an exponential, with 
loss of the shoulder. As is well known, the shoulder in the curve represents 
repair of "repairable radiation damage", and can be quite clearly seen in the 
control survival curve shown in Fig 4.11. Loss of the shoulder can then be 
construed to represent impaired repair of repairable cellular damage. The 
mechanism by which mitoxantrone does this is somewhat unclear. One possibility 
is the suppression of ATP, which can be presumed to be a very important energy 
source for repair of cellular radiation damage. However, it was not possible to 
demonstrate that ATP levels were indeed suppressed at the concentration of 
mitoxantrone used, viz 0.5~g/ml. The ATP content in CaNT tumours treated with 
mitoxantrone following x-irradiation showed an increase 1.37 times compared with 
controls, i.e. a small augmentation. However, when this result is compared with 
that obtained where x-irradiation took place in the absence of this cytotoxic 
drug (3.8 times that of the controls) a significant inhibition of the ATP 
production occurred. It must be noted that all measurements were made at the 
same time following irradiation. The results presented here thus have 
implications for radiation therapy, where combining radiation and mitoxantrone 
could lead to a therapeutic gain. 
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It was considered that if the glycolytic pathway could be inhibited, another 
mechanism would then exist to deplete energy production. It was thought that if 
there was impaired or low conversion of mannose to glucose-6-phosphate in tumour 
cells, then by supplying excess mannose, energy production would be inhibited. 
Measurements of phosphomannose isomerase (which converts mannose-6-phosphate to 
fructose-6-phosphate) in both the CaNT and Fib/t tumours showed an activity 
comparable to that found in the liver (Chapter 4, Section 4.3.1). This line of 
investigation was not pursued futher. 
Part of the present investigation involved ultrastructural studies of the CaNT 
' 
tumour following doses of 10 and 100 Gy x-rays, and using a range of 
magnifications from 4900 to 23 000. Following irradiation with 10 Gy no 
morphological changes could be observed in comparison with the non-irradiated 
control tumours. However, after x-irradiation with 100 Gy distinct 
morphological alterations occurred in the tumour tissue e.g. clear degeneration 
of the cristae and matrix of mitochondria (Chaper 4, Section 4.9). 
Baldetorp et al (257) have reported the effects of ionizing radiation in an 
experimental in vitro system using the ciliary cells of the tracheal mucous 
membrane of rabbits. The specimens were examined in the electron microscope 
after irradiation. After 10 Gy of x-irradiation no morphological changes were 
observed compared with the control material. Distinct morphological alterations 
in the mitochondria occurred following higher radiation doses of 40, 50, 60 and 
70 Gy. The same group also studied the effect of irradiation on tracheal 
ciliary cell activity in rabbits (59). The immediate response of the ciliary 
activity to 10 Gy of ionizing radiation was presumed to be due to changes of the 
mitochondrial membrane permeability, resulting in a diffusion of a stored pool 
of ATP to the extra-mitochondrial space and to an increased enzymatic activity 
during the ATP hydrolysis in the cilia. This explanation is consistent with the 
results obtained in this thesis, where ATP content increases in tumour cells 
after ionizing radiation (Chapter 4, Sections 4.1.4.1, 4.1.4.2, 4.1.4.3). 
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As explained above (Chapter 4, Section 4.9) many cellular inclusions were 
observed which are consistent with typical viral particle contamination of 
murine tumours. Retrovirus type C mouse leukemic virus has an appearance, size 
and location typical of the observed particles and as has already been noted is 
also known to bud from the cell membrane. This common contaminant arises from 
the mouse's blood and is not thought to be more than an incidental finding whose 
presence does not affect the investigations and results of this thesis. 
Until now, the discussion has centred around the effects of ionizing radiation. 
It is intended now to turn to a dicussion of the effects caused by magnetic 
fields. Molecular or subcellular structures with anisotropy in magnetic 
susceptibility will be influenced by a torque depending on the orientation to 
the applied magnetic field, which is proportional to the strength of field 
squared. This axis of rotation of this twisting force is aligned with the field 
and is several orders of magnitude higher on a magnetically anisotropic body 
than on an isotropic one. These physical effects in turn modify various 
chemical processes as well as some electrochemical processes resulting in a 
variety of biological effects. In the present research work, the effects on 
growth rate have been studied in CaNT murine tumours in CBA mice when exposed to 
a static magnetic field (0.5 Tesla) using single and multiple exposures. 
Multiple exposures also took place in static magnetic field (0.5 Tesla) 
simultaneously with a superimposed varying magnetic gradient field 5 x 10-3 
Tesla/m. The tumours exhibited a very significantly delayed tumour volume 
doubling time and growth rate over 7 days (258). The result is described in 
Chapter 4 (Sections 4.6.1, 4.6.2). These findings are consistent with several 
reports (28, 259, 260, 261) in which the biomagnetic effects on growth rates in 
tumour cells were studied. Mulay et al (262) have reported the effect of a 
magnetic field (0.04 Tesla) on Sarcoma 37 and ascites tumour cells. The control 
tumour cells showed normal growth even after 18 hours, whereas most tumour cells 
exposed to the magnetic field showed complete degeneration at the end of this 
period. 
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As has already been considered in Chapter 2, neoplasms are caused by some 
breakdown in their control mechanism and tumour cells proliferate with little 
restraint. They migrate to various parts of the body and they generally lack 
any cohesive organization. One of the first observations characterizing the 
pleiotropic phenotypes of tumour cells is the general inability of the tumour 
cells to communicate intercellularly in a proper fashion (80, 263). It has been 
proposed that extensive interleaving (junctions) of thin cytoplasmic membranes 
is responsible for growth control. This implies that magneto-stresses on cell 
membranes may affect their vital functions. Kim (11) suggested that tumour 
cells, that is, at least some of them, are more susceptible to magnetic-fields 
than normal cells, since they are less organized and less cohesive. This is 
because their surfaces are more negatively charged than normal cell surfaces, 
they have larger dielectric constants and they fail to for·m effective membrane 
junctions for intracellular communication. 
Magnetic fields generate stresses and torques which affect biological processes 
by distorting membranes and membrane components and the orientation of various 
intra-cellular structures. These physical and chemical actions may be 
translated into such biological effects as growth retardation. The effect of 
magnetism on the biophysical and biochemical properties of cell components is 
not fully understood. It is possible that cells contain liquid crystal 
substances and that magnetic fields transform smectic crystals to nematic 
crystals (264). It is also possible that magnetic torques which distort forces 
between electric dipoles, may distort chemical bonds~ 
There is another explanation about the implications of the growth rate of tumour 
under exposure to magnetic fields which can be given. Electron transfer 
reactions are common in both chemical and biochemical transformations, e.g. 
electron transfers during oxidative phosphorylation. Electrons are fed into 
this sequence by oxidation of compounds derived from dietary fuels. In other 
words all of the useful energy liberated during the oxidation of fatty acids and 
amino acids and nearly all of that from the oxidation of carbohydrate is made 
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available within the mitochondria as reduced equivalents (H or electrons). This 
is accomplished in the mitochondria via the respiratory chain which is concerned 
with the transport of reducing equivalents and their final reaction with oxygen 
to form water, together with the machinery for trapping the liberated free 
energy as high-energy phosphate. These reactions involve the formation of 
transient free radicals. For example, the ubiquinones may be reduced one 
electron at a time through the semiquinone free radical, or may be reduced 
directly to the dihydroquinone by two electrons. This free radical, initially 
in the singlet state, will develop into the triplet state. External 
perturbations of the transient free radical may permit some control over the 
course of the electron transfer reaction during oxidative phosphorylation and 
perhaps may perturb the synthesis of high energy phosphate. The transient free 
radical lives about 20 ns without any external perturbation, but the lifetime of 
free radicals increase with increasing magnetic field from 0 to 0.04 Tesla by 
approximately 25% (31). It is possible that this perturbation can be used to 
control the lifetime of the initially formed transient free radical in the 
oxidative phosphorylation. The external perturbation mediated magnetic field 
may alter the oxidative phosphorylation, which interferes with ATP synthesis 
since energy in the form of ATP is required for growth, with the net result 
being a growth delay in tumours. 
The first of these mechanisms of interaction (depending on magnetic anisotropy) 
involves a well established physical law which has been known for many decades. 
The second effect, concerned with properties of transient free radicals, was 
first described recently (265) and its fundamental mechanism is less well 
understood. Yet the resulting biophysical manifestation is clear. Explanations 
given are not mutually exclusive, and both can be involved in part or totally to 
explain to biomagnetic properties of tumours described in this thesis. 
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CONCLUSIONS 
Adenosine-5'-triphosphate (ATP) most probably has a major role in repair to 
intracellular damage after ionizing radiation in the tumours studied. The 
increased levels of ATP following irradiation described in this thesis are 
probably related to physiological demands which follow radiation injury (199, 
200, 201). An energy provision is necessary for repairing appropriate damage in 
rodent tumours. This can be expressed as a transient increased cellular demand 
for glucose, which in turn may be due to an increased amount of ATP needed for 
cellular repair processes (266). This energy may be supplied by anaerobic 
glycolysis in the cytosol and total oxidation in the mitochondria. It is 
necess~ry therefore to activate demands for prompt energy by mobilizing glucose 
rapidly from glycogen. This increase in metabolic rate is expressed in terms of 
non-equilibrium reactions which increase glycolysis, by accelerating enzymatic 
activation and free energy (ATP) yield and could be related to negentropic 
repair mechanisms and higher entropy in the entire injured cell. The major 
supply of ATP to repair this damage could be from the mitochondria of adequately 
oxygenated cells. Consequently in tumour ATP content, there is greater 
concentration per unit mass, or per cell, in the aerobic fraction than in the 
hypoxic fraction of the tumour tissue. 
It can be suggested that the enhanced tumour glucose-6-phosphate dehydrogenase 
activity which has been measured in this work, may also be a consequence of 
cellular requirements for increased metabolism to maintain homeostasis during 
repair of radiation damage (233, 235). This enzyme is the first enzyme in the 
pentose phosphate pathway and its increased activity can be associated with an 
enhanced rate of nucleic acid synthesis, for which glycogen is a reserve 
substrate (234). 
Isocitrate dehydrogenase and glucose-6-phosphate dehydrogenase mediated 
reactions are sources of reducing equivalents. The augmentation in the specific 
' 
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activities and increased reducing equivalents associated with these enzymes may 
give protection against radiation damage. The explanation of the above 
metabolic responses to irradiation is complex and cannot be explained only in 
terms of direct radiation effects. 
Modification of the cellular energy supply by using cytotoxic compounds, might 
provide a way to modulate cellular repair processes (23, 187, 254). 
Mitoxantrone has been shown to decrease ATP production in rat heart slices in 
vitro (148), and in this present work it was shown for the first time that this 
drug also decreases ATP production in tumours as well as in cells in culture. 
Irrespective of the mechanism involved in the phenomena of repair, the present 
data show that if ATP production falls by interference from mitoxantrone, repair 
processes may be markedly inhibited. Hence, for there to be effective repair 
processes, a higher ATP production must be superimposed upon the requirement for 
the normal maintenance activities of the tumour cells. 
With regard to the effects caused by magnetic fields, the significant 
conclusions are that this quality of radiation which can generate stress and 
torques within the rodent tumours, does affect their growth rate, possibly by 
distorting membranes, membrane components and disturbing the orientation of 
various intracellular structures, so affecting energy production, energy demand 
and other metabolic processes (31). The magnetic fields of 0.5 Tesla, used in 
this work, have sufficient energy density to modify the life time of transient 
free radicals in the normal biochemical processes. The fields were observed to 
cause a delay in the growth of the experimental tumours (11). This approach 
provides insight into the interactions between this type of non-ionizing 
radiation and tumour cell metabolism. 
It is hoped that the work presented here gives increased understanding of basic 
radiobiological mechanisms in tumour cells subjected to ionizing and, 
non-ionizing radiations, together with indications that can lead to improved 
radiotherapeutic strategies. 
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APPENDIX A 
THERMODYNAMIC RELATIONS 
Thermodynamic concepts used in this thesis, such as entropy and Gibbs free 
energy, will be defined in this appendix and some important thermodynamic 
relations which involve them will be briefly described. 
A .I. EntropY 
The second law of thermodynamics is a statistical law which can only be 
• 
applied to a system consisting of a large number of particles, as, for 
example, an assemblage of molecules. The probability that all the 
molecules in a macroscopic amount of gas will be equally spaced and move in 
an ordered manner relative to each other is vanishingly small. This is 
because as a result of impacts the distances of separation and velocities 
of the molecules will vary continuously. The establishment of a condition 
of chaotic movement and of random distrib~tion, which occurs quite 
spontaneously, is far more probable than an ordered state. All spontaneous 
processes are accompanied by an increase of entropy. It is possible, 
therefore to regard entropy as a measure of t.he 11 randomness 11 or 11 disorder 11 
in a given system, and to suppose that all natural processes lead to an 
increase in disorder. Since a disordered state is usually more probable 
than one of complete order, entropy and probability are evidently related. 
L. Boltzmann defined the thermodynamic probability of a system as the ratio 
of the probability of an actual state (microstate) to one, having the same 
total energy and volume, in which the molecules are completely ordered. If 
S is the entropy and W the thermodynamic probability of a system then it is 
possible to write S=f(W). 
W is also known as the number of microstates. To ascertain the nature of 
the function, consider two systems having entropies s1 and s2 and 
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probabilities W1 and w2• The entropy S of the combined system is s1 + s2 
whereas its probability~! is the product (W1 x w2) 
so that 
S = s1 + s2 = f (W1 W2) (Equation A.1) 
but since s1 = f (W1) and s2 = f (W2), 
it follows that f (W1 w2) = f (W1) + f (W2) 
To satisfy this condition it is obvious that the function must be 
logarithmic and hence it is possible to write (Equation A.2) 
S = K ln W + constant (Equation A.2) 
The constant K was shown by Boltzmann to be equal to the gas constant per 
single molecule, i.e. R/N, where R is the molar gas constant and N is the 
Avogadro number. If it is assumed that the entropy depends only on the 
thermodynamic probability of the system (Equation A.3) then 
S = K ln W (Equation A.3) 
This means that in a completely ordered arrangement i.e. W = 1, which might 
exist in the solid state at absolute zero, the entropy is zero. 
A.2 Gibbs Free Energy 
The entropy change that must be considered if the direction of chemical 
reaction is to be deduced is that of the "universe of the reaction". This 
entropy change is the sum of that occurring in the system and that 
occurring in the therma 1 surroundings.· 
Consider a chemical reaction system in which the reaction occurs at 
constant temperature and constant pressure. The entropy change in the 
thermal reservoir is -q/T or -MVT (where H is the enthalpy which the sum 
of internal energy and external work done). Both this 
therma 1-energy-reservoi r term -6H/T and 6S, .the entropy change in the 
system as a result of the reaction, can be deduced from data for the 
reactants and products. Thus from properties of the system we can evaluate 
6S . (the entropy change of the "universe of the reaction") UlllV 
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~5univ = ~s + ~5therm res = ~s ~H (Equation A.4) 
T 
(t.S is the entropy change of the system as a result of the reaction and 
~Stherm res is the entropy change in the thermal reservoir). 
To convert the expression in Equation A.4 to one with the more familiar 
units of energy, we multiply it by T, the constant absolute temperature of 
the reaction, to give 
T ~S - ~H 
then we introduce a symbol ~G where 
-~G = T~S - ~H or ~G = ~H - T~S (T = constant) {Equation A.5) 
This function, G, whose change is ~G in the above example, is called the 
Gibbs free energy. 
The free-energy function, from which the relation of Equation A.5 stems, is 
defined by 
t 
G = H - TS (Equation A.6) 
The defining equation H = E + PV, is substituted in Equation A.6 to give 
G = E + PV - TS (Equation A.7) 
For an infinitesimal change in G one now has 
dG = dE + PdV + VdP - TdS - SdT (Equation A.8) 
For constant temperature and constant pressure processes as in living 
organism (where dP = dT = 0), the Gibbs free energy is therefore defined as 
dG = dE + PdV - TdS {Equation A.9) 
Change in free energy (~G) is that portion of the total energy change in a 
system which is available for doing work. In other words Gibbs free energy 
is a thermodynamic function (or function of state) which describes a 
system's maximum potential for doing work. 
The second law of thermodynamics can therefore also be stated in these 
terms, spontaneous reactions are those which, when carried out under 
suitable conditons, can be made to perform work. Since ~G is a 
thermodynamic function, it is possible to obtain a value for an over-all ~G 
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of a complete reaction, say in a metabolic process, by adding the values of 
tG for each component part of the total reaction. 
Although thermodynamic theory was first derived for simple mechanical 
systems (e.g. a perfect gas) its principles are universal and have been 
applied to complex biological systems. 
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APPENDIX B 
METHODS OF CALCULATION 
The most important formulae required for calculations concerning 
spectrophotometry and statistical analysis are given in this Appendix, together 
with some remarks about their interdependence, their components and their units. 
B.1 Absorption spectrum and extinction coefficient 
When light or other radiation passes through matter, some is absorbed and 
some transmitted. This situation is described by the Lambert-Beer law 
which states that: 
E = E X c X d (Equation B.1) 
where E is extinction; c is concentration; d is light path length and E is 
the molar extinction coefficient. E is defined by E = log (1 0/I) where 10 
and I are intensities of incident and transmitted radiation respectively. 
The law states that the extinction is proportional both to the light path d 
and the concentration c of the absorbing substance. The proportionality 
constant E is the extinction of the substance in question at a 
concentration of unity with a light path of 1cm. 
If, as is usual in some countries, the quantity of substance in moles is 
associated with a volume in cm 3 (i.e. mol/ml), the dimensions found forE 
are (cm 2/mol) as is shown by the following relation. 
E = log {1 0 /I) 1 
c x d { (mol/cm3} x em = cm 2 /mol } 
(Equation 8.2) 
However for greater convenience the concentration (c) is also expressed in 
(mol/litre or M). Hence the molar extinction coefficient then has 
( -1 -1) dimensions M .em . 
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The following symbols and numerical values are also used in this thesis. 
E molar extinction coefficient for NADP = 6.22 x 103 (M- 1.cm-1) or 
6.22 (cm2/~mol) 
~E extinction change 
V assay JOlume (mt) 
v = volume of sample used in assay (mt) 
d = light path length (em) 
c = concentration (mol/litre) or (nmol/mg) 
t = time (min) 
~t = interval between measurements (min) 
8.2 Adenosine-5'-triphosphate concentration 
When a biochemical reaction takes place it follows from Equation 8.1 that 
{nmol/rnt} (Equation 8.3) 
If there is complete conversion (c2 = 0) then c can be written for ~c. 
For the determination of the concentration of the sample the ratio of assay 
volume: sample volume (V:v) is to be considered: 
~E X v 
c = £ x d x v {nmol/ml} (in the sample) (Equation 8.4) 
From the concentration (c(measured)) of the sample of volume v (e.g. tumour 
tissue extract) the ATP content of the tissue under investigation (whole 
' 
tumour) can be calculated by relating to its concentration in the sample: 
c( s ed) {nmol/mt} ATP C t t ~m_e_a __ u_r~~--~~~ 
on en = c(weighed out) {mg/mt} {nmol/mg} (Equation 8.5) 
8.3 Enzyme activities 
The enzymes studied in this thesis were: 
1. Glucose-6-phosphate dehydrogenase (G6P-DH) 
2. Isocitrate dehydrogenase (ICDH) 
- 167 -
3. Phosphomannose isomerase (PMI) 
For measuring the rate of substrate conversion or product 
accumulation, change in concentration per unit time (min) was used 
Volume activity = £ x ~ x v x 6E/6t (~mol/min/ml) 
(Equation B.6) 
Specific activity= d vvx 6E/6t (~mol/min/mg) 
£ x x cprotein 
(Equation 8.7} 
The specific activity is defined as ~mol of substrate converted per 
min per mg of enzyme. 
Turnover number = (substrate converted) (amount of enzyme x time) 
Units are ( 11mo 1 /mi n/ml) _ {mg protein/ml) - ~mol converted/min/mg prote·in 
8.4 Statistical Methods (267) 
I. The mean (x) is given by 
( -) - ~X X --n 
(Equation 8.8) 
(Equation 8.9) 
Where ~x = sum of all observations in the sample population 
n = number of observations 
II. The standard deviation (s) is given by 
s = ((~xz - (~x)z;n)/(n-1))! (Equation 8.10) 
Where rx 2 = the sum of the squares of all observations in the sample 
population 
III. The standard error of the mean (S.E.M.) is given by 
S.E.M. = s/(n)i (Equation 8.11) 
IV. The significance of difference between two mean values was ascertained 
by using Student•s two-tailed t test, with (n1 + n2 - 2) degrees of 
freedom (Equation 8.12) 
where xl and x2 are the mean values of observations, sl and 52 are the 
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standard deviations and n1 and n2 are the numbers of observations. 
(Suffices 1 and 2 denote first and second sample populations 
respectively). The value of P was ascertained from appropriate 
tables. 
V. The coefficients of regression {a and b) in the regression line whose 
equation is y = a + bx and the coefficient of determination (r2) are 
given by 
b = (Exy - (Ex)(Ey)/n)/(Ex2 - (Ex)2/n) 
a = (Ey)/n - b(rx)/n 
2 = ~Exy - (Ex) (E))/n)2 
r Ex2 - (Ex)2/n (Ey2 - (Ey)2/n) 
(Equation 8.13) 
{Equation 8.14) 
{Equation 8.15) 
The formulae given in this Appendix are applied in Chapters 3 and 4 of 
this thesis. 
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